Next Article in Journal
Influence of the Alcoholic/Ethanolic Extract of Mangifera indica Residues on the Green Synthesis of FeO Nanoparticles and Their Application for the Remediation of Agricultural Soils
Next Article in Special Issue
Fruits Vinegar: Quality Characteristics, Phytochemistry, and Functionality
Previous Article in Journal
Unravelling the Photoprotection Properties of Garden Cress Sprout Extract
Previous Article in Special Issue
Janerin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis Involving the MAPK Pathway in THP-1, Leukemic Cell Line
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Lamiaceae in Mexican Species, a Great but Scarcely Explored Source of Secondary Metabolites with Potential Pharmacological Effects in Pain Relief

by
Alberto Hernandez-Leon
1,†,
Gabriel Fernando Moreno-Pérez
1,2,†,
Martha Martínez-Gordillo
3,
Eva Aguirre-Hernández
4,
María Guadalupe Valle-Dorado
5,
María Irene Díaz-Reval
6,
María Eva González-Trujano
1,* and
Francisco Pellicer
1
1
Laboratorio de Neurofarmacología de Productos Naturales, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City 14370, Mexico
2
Programa de Posgrado en Ciencias Biológicas, Facultad de Medicina, Universidad Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico
3
Herbario de la Facultad de Ciencias, Departamento de Biología Comparada, Facultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico
4
Laboratorio de Productos Naturales, Departamento de Ecología y Recursos Naturales, Facultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico
5
Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico
6
Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima 28045, Mexico
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2021, 26(24), 7632; https://doi.org/10.3390/molecules26247632
Submission received: 20 November 2021 / Revised: 5 December 2021 / Accepted: 9 December 2021 / Published: 16 December 2021

Abstract

:
The search for molecules that contribute to the relief of pain is a field of research in constant development. Lamiaceae is one of the most recognized families world-wide for its use in traditional medicine to treat diseases that include pain and inflammation. Mexico can be considered one of the most important centers of diversification, and due to the high endemism of this family, it is crucial for the in situ conservation of this family. Information about the most common genera and species found in this country and their uses in folk medicine are scarcely reported in the literature. After an extensive inspection in bibliographic databases, mainly Sciencedirect, Pubmed and Springer, almost 1200 articles describing aspects of Lamiaceae were found; however, 217 articles were selected because they recognize the Mexican genera and species with antinociceptive and/or anti-inflammatory potential to relieve pain, such as Salvia and Agastache. The bioactive constituents of these genera were mainly terpenes (volatile and non-volatile) and phenolic compounds such as flavonoids (glycosides and aglycone). The aim of this review is to analyze important aspects of Mexican genera of Lamiaceae, scarcely explored as a potential source of secondary metabolites responsible for the analgesic and anti-inflammatory properties of these species. In addition, we point out the possible mechanisms of action involved and the modulatory pathways investigated in different experimental models. As a result of this review, it is important to mention that scarce information has been reported regarding species of this family from Mexican genera. In fact, despite Calosphace being one of the largest subgenera of Salvia in the world, found mainly in Mexico, it has been barely investigated regarding its potential biological activities and recognized bioactive constituents. The scientific evidence regarding the different bioactive constituents found in species of Lamiaceae demonstrates that several species require further investigation in preclinical studies, and of course also in controlled clinical trials evaluating the efficacy and safety of these natural products to support their therapeutic potential in pain relief and/or inflammation, among other health conditions. Since Mexico is one of the most important centers of diversification, and due to the high endemism of species of this family, it is crucial their rescue, in situ conservation, and investigation of their health benefits.

Graphical Abstract

1. Introduction

The term Labiatae comes from the Latin word “labia”, which means “lip”, and refers to the peculiar morphological characteristic of all the species that belong to this family, which have the corolla split into an upper lip and a lower one. This term precedes the name Lamiaceae, which comes from the Greek “laimos” referring to the “gaping mounth” of the corolla [1]. The Lamiaceae family belongs to the order Lamiales, in the clade Lamids, in the Eudicots [2]. It is the sixth largest family of angiosperms comprising 12 subfamilies, 16 tribes, 9 subtribes, 236 genera, and over 7173 species [1,3]. A wide range of substances isolated from plants belonging to this family produce antibacterial, cytotoxic, antioxidant, anti-inflammatory and insecticidal activities [4]. Various studies report that the members of this family are a source of phytochemical compounds with health benefits or play an active role in the improvement of diseases, mainly due to the content and type of compounds, the main ones being essential oils, terpenoids, phenolic acids and flavonoids [5,6], many of which can be used to relieve pain.
It is well documented that healing with medicinal plants is as old as humanity itself, perhaps mainly due to pain. Hippocrates (5th century BC) was the first Greek writer to use the word analgesia in a medical rather than a philosophical context, as well as derivative words related to pain when using plants to relieve it. Dioscorides (1st century BC) was a Greek philosopher who explored the therapeutic properties of plants, including those used for pain relief, describing the narcotic effects of the plant mandragora. As a military physician and pharmacognosist, Dioscorides differentiated among a few species from the genus Mentha (Lamiaceae), which were grown and used to relieve headache and stomachache. Hey used expressive and precise adjectives and well-defined characteristics of pain, such as location, duration, or relation to other symptoms, to elucidate a disease process [7].
Nowadays, according to the International Association for the Study of Pain, “pain” has been defined as an unpleasant sensory and emotional experience associated with, or resembling experiences associated with, actual or potential tissue damage [8]. It can be classified as functional (nociceptive or inflammatory) [9] or dysfunctional (neurogenic, neuropathic and psychogenic) because of its origin or etiology [10], or as acute or chronic because of its temporality [9]. In acute pain, nociceptors are activated in the site of tissue damage, while chronic pain is commonly triggered by injury or an illness, and it can be perpetuated by factors other than the cause of pain [10]. Acute pain associated with tissue damage can last for less than 1 month, but sometimes it can last for more than 6 months, at which point it becomes chronic pain. Preclinical studies have shown that neuronal expression of new genes (the basis for neuronal sensitization and remodeling) occur within 20 min of injury. Chronic pain can cause long-term behavior and histological changes within approximately one day after interventions, such as transient nerve ligation [8]. Among the characteristics that commonly occur in patients with chronic and dysfunctional pain are hyperalgesia (exacerbated sensitivity to painful stimuli), allodynia (painful response to harmless stimuli) and hyperesthesia (abnormal sensitivity to sensory stimuli) [11].
Nociception is not the same as the term pain, it is the mechanism through which harmful stimuli are transmitted to the central nervous system (CNS). This term is used in the preclinical evaluation of the plants or bioactive constituents. Nociceptors are neurons sensitive to noxious stimuli and are in the skin, blood vessels, muscles, fascia, joints and viscera. They are predominantly myelinated (A-δ) or unmyelinated (c) fibers, activated by noxious stimuli (mechanical, thermal, cold and chemical), which carry these signals to the CNS [12,13,14]. All tissues, with the exception of the CNS neuropil, are innervated by afferent fibers, although their properties differ markedly, depending on whether they are somatic (skin, joints, muscles) or visceral fibers (cardiovascular or respiratory tissue, gastrointestinal or renal tract), and reproductive systems [15].
Pathophysiological mediators of pain and inflammation are generated by several important sources. These mediators can act through a multiplicity of receptors that are widely distributed in central and peripheral nerves and coupled to heterotrimeric G proteins, as occurs in opioids and 5-HT1A inhibitory receptors associated with multiple second messengers formation (cAMP, cGMP, DAG, IP3, intracellular Ca+2, NO) and protein kinases (A, C or G) to promote the phosphorylation of multiple targets [10]. Other pharmacological receptors involve activity through ion channels, e.g., excitatory amino acids or acetylcholine (which activates the nicotinic receptor), to control the ionic permeability of the membrane and muscle contraction [15,16].
In the case of inflammation, it involves an integration of several inflammatory mediators, such as prostaglandin E2, bradykinin, substance P, histamine, adenosine and serotonin, sensitizing nociceptors after mechanical and thermal stimuli. It is commonly reported that mediators in an inflammatory condition are cytokines. In this respect, Toll-like receptors (TLRs) activate proinflammatory cytokine profiles in macrophages, altering the homeostatic regulation of the immune system. Macrophages are essential components of the innate and adaptive immune systems, and therefore play a central role in inflammation, host defense, and tissue repair [17,18]. Depending on the microenvironment, these cells are functionally classified into two main types: classically activated proinflammatory M1 macrophages and alternately activated M2 macrophages. M1 macrophages are induced by Th1 cytokines such as interferon γ (IFNγ) and tumor necrosis factor α (TNF-α) or by lipopolysaccharide (LPS) and typically attack microorganisms and tumor cells, and express inducible nitric oxide synthase (iNOS) and most of the TLRs [18]. In contrast, M2 macrophages are induced by Th2 cytokines such as interleukins (ILs)-4, -13, and -10 and transforming growth factor β (TGF-β). Könner and Brüning [19] demonstrated that TLR2 and TLR4 are closely related to the systemic inflammatory response. TLRs (of which there are 10 types in humans and 12 in mice), contain adapter proteins, the recruitment of which is followed by a signaling pathway that activates nuclear factor kappa B (NF-kB), activator protein 1 (AP-1), signal transducer and activator of transcription 1 (STAT-1) and interferon regulatory factor (IRF), which mediate inflammation as well as cytokines release [20,21]. NF-kB is an important nuclear transcription factor in the regulation of the inflammatory response. It participates in biological processes that involve inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis [22]. NF-kB is regulated by binding to inhibitory molecules such as the nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IkBα). The NF-kB p65 subunits dissociate from their inhibitory protein IkBα by translocating from the cytoplasm to the nucleus where they influence the expression of proinflammatory cytokines such as TNF-α, IL-1β, IL-6 and IL-8 [23]. Therefore, the prevention of nuclear translocation of NF-kB may work as a potential therapeutic target. The transcription factor Nrf2 is largely responsible for the inducible expression of proteins involved in the response to oxidative stress, cell protection and the inhibition of the expression of inflammatory cytokines, such as IL-6 and IL-1β. Furthermore, Nrf2 is associated with the NF-kB-mediated transcription of proinflammatory cytokines genes [24]. The signaling pathway of mitogen-activated protein kinases (MAPKs) consists of a family of serine/threonine kinases that are activated by several stimuli, including different inflammatory factors [25]. MAPK proteins control fundamental cellular processes, such as proliferation, differentiation, metabolism, inflammation and apoptosis. As MAPK and NF-kB can synergistically collaborate to induce proinflammatory cytokines [25,26], secondary metabolites of phytopharmaceuticals with inhibitory capacity of NF-kB and MAPK may have potential therapeutic advantages in the treatment of inflammatory diseases. It has been demonstrated that many plant constituents can interact with one or more than one of those previously mentioned biological targets, which are involved in producing, enhancing or relieving pain alone, or are associated with inflammation because of tissular damage.
Several aspects of Lamiaceae are addressed in this review, emphasizing that Mexican genera have not been explored enough as source of medicinal species. We provide evidence of the minimal number of species explored to investigate potential secondary metabolites responsible for their antinociceptive and anti-inflammatory properties and point out the mechanisms of action involved and modulatory pathways by using different experimental models. The integration of relevant information on some species belonging to Mexican genera of Lamiaceae and substances derived from these and other investigated plants reinforces the evidence already reported regarding various species from different regions around the world on their medicinal properties as promising alternatives for potential analgesics and anti-inflammatory drugs.

2. Results

2.1. Lamiaceae Description

The species belonging to this family are generally characterized by being annual or perennial herbaceous plants or shrubs, sub-shrubs and less commonly trees or vines; occasionally with stolons or rhizomes; often with aromatic oils; stems being erect or prostrate, generally tetragonal, due to the presence of large bundles of collenchyma, with no spines [27], and with or without a glandular trichome indument. Opposite leaves, generally decussate, sometimes whorled, simple or less frequently compound (Vitex), dentate or crenate; the petiole being present or absent; and stipules being absent [28].
Terminal or axillary inflorescences, thyrsoids, are usually found with cymes or whorls arranged in spikes, racemes, panicles or a capitulum, and bracts are usually present, being persistent or deciduous. The flowers are usually bisexual, hypogynous, zygomorphic, and rarely actinomorphic; have a persistent, gamosepalous, tubular to widely campanulate calyx; have four to five (to nine) lobes, which are imbricated; have a gamopetalous corolla, generally with five lobes, equal or sub-equal, frequently bilabiate, and in that case the upper lip bilobed and the lower lip are trilobed, with imbricated lobes, and a short or long tube; have four stamens, which are didynamous, rarely equal, sometimes reduced to two and sometimes with staminodia present, and epipetalous; generally have free filaments; have anthers longitudinally dehiscent; have a hypogynous disc, which usually fleshy, and sometimes divided into four glands; have a bicarpellary gynoecium, which is usually tetralocular due to a false septum, upper ovary, one style, which is gynobasic, and less frequently terminal, and a filiform, usually with two stigmatic lobes, equal or unequal; have four ovules, one per locule, erect, and the fruit is tetralobed and, indehiscent, usually with four nuts, which are dry, smooth or slightly tuberculated or reticulated-rough. The seeds are usually number four [3,27,28]. Photographs providing examples of species of Lamiaceae from Mexican Salvias (Calosphace subgenus) are shown in Figure 1.

2.2. Geographical Distribution

In various regions worldwide, members of the Lamiaceae can be found. This family contains 236 genera and approximately 7173 species, growing in areas with tropical and temperate climates from 0 to 2500 m above sea level [3]. Several species are found to be abundant in mountainous areas, with a temperate climate, although it is possible to find the Hyptis and Asterohyptis genera in dry and hot areas [28,29]. There are six regions of high diversity in the world [27,30]: the Mediterranean and Central Asia [31], Africa and Madagascar [32], China [33], Australia, South America [34] and North America (including Mexico) [28,35] (See Figure 2A).
In Mexico, Lamiaceae is the family with the eighth greatest diversity and the number of species of this family in Mexico represents 5.5% of the species belonging to this family worldwide. For that reason, Mexico can be considered one of the most important centers of diversification, and due to the high endemism of this family, it is crucial for the in situ conservation of this family [35] (Figure 2B).

2.3. Lamiaceae and Some of Its Genera in Mexico

Lamiaceae is one of the most diverse families in Mexico, after only Asteraceae, Fabaceae, Poaceae, Orchidaceae, Cactaceae, Euphorbiaceae, and Rubiaceae, representing 13.55% of the genera and 8.23% of the world’s species, with an endemism of 66.2% [35]. Mexico has 31 genera and 598 species. The most diverse genus is Salvia, with 306 species, where the subgenus Calosphace is one of the most diverse, with 295 species from the 580 included in the group [36]. Oaxaca is the state with the greatest diversity, while Jalisco houses the largest number of endemic species. Even though no genus of the family is endemic in the country, plants of the Cunila or Hedeoma genera have an endemism of up to 60% [35].
According to Harley et al. [3], from the 236 genera of Lamiaceae, 226 were assigned to seven subfamilies: Ajugoideae, Lamioideae, Nepetoideae, Prostantheroideae, Scutellarioideae, Symphorematoideae, and Viticoideae. Cymarioideae, Peronematoideae, and Premnoideae were added later [37]. From these, six are found in Mexico. Finally, Callicarpa and Tectona were transferred from the Verbenaceae family being recognized as independent subfamilies latterly [31] (See Figure 3).

2.4. Pain and Some of Mexican Lamiaceae Genera to Alleviate It

Currently, a wide variety of herbs are found in the markets of several cities around the world [38], where the Lamiaceae family contains species of economic value because of its culinary or flavoring and medicinal properties. Species from this family have been widely used since ancient times, as spices and herbal teas in traditional medicine. Velongiarious members of this family are specifically used as a source of essential oils [27]. In fact, a variety of healing properties is attributed to each plant from Lamiaceae [29]. Several of them are repeatedly recommended to treat the same disease, suggesting that similar constituents are included in them [39] (Table 1). Despite this, reports describing pharmacological evidence on the antinociceptive and anti-inflammatory effects, bioactive compounds isolated and mechanism of action from Mexican Lamiaceae species are scarce in the literature. Most of the investigations have evaluated polar extracts from nature exploring the following genera: Hyptis, Lavandula, Leonurus, Melissa, Marrubium, Mentha, Ocimum, Origanum, Sage, Satureja, Stachys, Scutellaria, Sideritis, and Teucrium [40]. Antinociceptive and anti-inflammatory effects were observed in polar extracts of Marrubium evaluated in formalin and carrageenan tests [41,42]. The analgesic-like response of the ethanol and hydroalcoholic extracts of Hyptis were evaluated in the writhing, formalin, tail immersion, carrageenan and hyperalgesia induced by glutamate or capsaicin tests in mice [43,44]. In a similar manner, the hydroalcoholic and aqueous extracts of species from Teucrium [45,46,47] or Scutellaria [48] have shown these activities. Analysis of hydroalcoholic extracts of species from the Stachys genus was carried out in mice using formalin, acetic acid-induced writhing, and light tail-flick tests [39], and that of Leonurus cardiaca L. was performed by using formalin, tail-flick, and hot-plate tests in mice [49].
In this manuscript, there is a special interest in plants belonging to this family, since they are widely and traditionally used in Mexican folk medicine for the relief of pain and/or inflammation, as are some species of the genera Salvia and Agastache.

2.5. Salvia Species Used in Pain Relief

Salvia’s name comes from the Latin salvare, which means to save and heal. One of the most ancient species of this genus is Salvia officinalis L. despite its Mediterranean origin, it is also of great medicinal use in Mexico, and is commonly known as sage. It was used by Egyptians, Greeks, and Romans to treat ulcerations. Nowadays, its anti-inflammatory properties are useful for the treatment of buccal conditions such as amigdalitis, faringitis and gingivitis, which might be because of the bioactive effect of components such as ursolic acid [91]. Its anti-inflammatory and antioxidant properties are influenced by the cytokine’s mediators considering its marked properties that inhibit the increase in IL-33 and TNF-α levels and the amplification of NF-kB expression and its activation [92].
Another species of Mediterranean origin with great medicinal utility to relieve pain in Mexico is Rosmarinus officinalis L., a Lamiaceae species recently reclassified as Salvia Rosmarinus Spenn. [40]. This species, cultivated in Mexico, possesses a broad spectrum of antinociceptive activities already evidenced in several acute and chronic experimental models, such as the writhing, formalin and gout arthritic-like pain tests, by preparing polar and non-polar extracts [93,94]. The responsible bioactive compounds of this species are flavonoids and triterpenoids, including hesperidin and ursolic, oleanolic, and micromeric acids [94]. Their mechanisms of action involve calcium channels and central inhibitory receptors or peripheral actions depending on the kind of pain induced [94,95]. The involvement of several mechanisms of action allowed the researchers to obtain a synergistic antinociceptive response in the presence of clinical analgesics and other medicinal plants used to alleviate pain [96].
Scarce information was found in the literature describing Salvia and Agastache genera distributed in Mexico and used for pain reliefDue to this, our group explored some of these genera to obtain pharmacological evidence of their medicinal properties, for example the cases of S. divinorum Epling & Jativa, S. semiatrata Zucc. and S. amarissima Ortega, as well as their main constituents as promising anti-inflammatory, antioxidant and antinociceptive agents, highlighting their mode of action in experimental models of pain as follows:
Salvia divinorum (1962) is a member of the Sage family that has been historically used for divination and shamanism by the Mazatecs from Oaxaca, Mexico, because of this hallucinogenic properties with a short duration. However, its leaf extracts have also been reported as useful medicinal species to relieve pain [97]. It has shown a wide spectrum of antinociceptive activities in preclinical studies using acute nociception in abdominal pain and in the neurogenic and inflammatory test of formalin [98] but also in chronic pain models, such as in neuropathic pain involving electroencephalographic changes [99]. Its bioactive compounds are from salvinorin, mainly salvinorin A, a neoclerodane diterpene, by involving kappa opioid, 5-HT1A serotonin and CB1 cannabinoid receptors as the main mechanisms of action [99,100,101].
Salvia amarissima is another endemic species in Mexico used in traditional medicine to treat disorders attributed to a cold state such as anxiety in the CNS, as well as gastrointestinal ailments and pain relief. It has been evaluated using several preclinical animal models of pain preparing different kinds of extracts, where medium polar and polar extracts have been the most bioactive [102]. It has also been observed that medium polar constituents are involved in the inhibition of neurogenic and inflammatory nociceptive responses through the participation of opioid and TRPV1 and 5-HT1A serotonin receptors [103]. The presence of a neoclerodane terpene named amarisolida A and the flavonoid pedalitin have been implicated in the bioactive and abundant constituents [102]. Their properties have also been reported in metabolic alterations such as diabetes, since they produce a significant antihyperglycemic action in vivo during an oral sucrose tolerance test by an alfa-glucosidase inhibitory activity [104]. The presence of flavonoids and terpenoid bioactive constituents has also been associated with another enzymatic and regulatory protein inhibition such as in protein tyrosine phosphatase 1B (PTP-1B), where different kinds of amarisolide have been characterized [105], as well as flavonoids such as rutin, isoquercitrin and pedalitin already associated with anxiolytic and/or antinociceptive activities [106,107]. Diterpenes derived from S. amarissima also possess modulatory capability in protein multidrug resistance and cytotoxic activity [108]. All these properties together suggest their useful application in the comorbidity of diabetes and pain such as in neuropathic pain or even in cancer.
Salvia semiatrata is a species used as a tranquilizer and to relieve pain in folk medicine in Santiago Huauclilla, Oaxaca, Mexico. Preclinical evidence was recently reported regarding its significant effects as an anxiolytic and antinociceptive in several experimental models in which the presence of the neo-clerodane diterpene 7-keto-neoclerodan-3,13-dien-18,19:15,16-diolide was identified as being partially responsible [109]. Pain is as strongly associated with anxiety as with depressive disorders, this comorbility can exacerbate the other significantly [110]. This kind of comorbidity can be modulated by the dual activity of herbal therapy, as it was observed in anxiolytic and antinociceptive effects of S. semiatrata using similar doses [109].

2.6. Agastache Species to Alleviate Pain and Inflammation

Agastache mexicana (Kunth) Lint & Epling is a plant in high demand that has long been used in Mexican folk medicine to treat anxiety, insomnia, and stomachache, among other afflictions associated to pain. A. mexicana has been divided in two subspecies: A. mexicana ssp. mexicana (Toronjil morado) and A. mexicana ssp. xolocotziana (Toronjil blanco), both of which are used in traditional medicine to alleviate visceral pain; however it was found that only a polar extract from ssp. mexicana produced spasmolytic-like effects [111]. This antinociceptive response was demonstrated in a significant and dose-dependent manner in an in vitro study, where ursolic acid and acacetin evaluated by the enteral and parenteral route of administration were both partial responsible constituents [112]. In contrast, ssp. xolocotziana was associated with a spasmogenic response. The spasmolytic effects of A. mexicana were related to an activation of nicotinic receptors, prostaglandins and calcium channels, but not nitric oxide mechanisms [113]. It is well-known that the abundant presence of certain constituents depends on the manner of preparation of the vegetal material [111]. In the methanol extracts of A. mexicana, the abundant presence of flavonoids such as acacetin and tilianin has been found [113]. Extracts from different polarities have been compared in different experimental models of pain, such as the writhing test in mice, the formalin and plantar tests in mice or rats, as well as the pain-induced functional impairment assay in rats (a gouty arthritis pain model) to demonstrate significant and dose-dependent antinociceptive responses. The effect was more evident in the less polar extracts in part due to the presence of ursolic acid [114].This triterpene produced its antinociceptive effect mediated by the presence of cGMP and an additive synergism with 5HT1A receptors, but also produced antagonistic activity towards TRPV1 receptors in neurogenic and inflammatory nociception with an ED50 = 44 mg/kg. A lower dosage was required to produce an antinociceptive effect in abdominal pain with an ED50 = 2 mg/kg [115].
Another species from Lamiaceae independent of the Agastache genus, but also known as “toronjil” in Mexico is Clinopodium mexicanum (Benth.) Govaerts, which is used in Mexican traditional medicine to induce sleep, as well as in a sedative and analgesic remedy with the common name of “Toronjil de Monte”. Its aqueous extract was able to inhibit central nociception using a thermal stimulus in mice supporting its depressant activity, where glavanone glycosides such as neoponcirin, poncirin and isonaringin were involved as bioactive constituents [51].

2.7. Secondary Metabolites Identified in Lamiaceae Species with Analgesic and/or Anti-Inflammatory Activities

Given the broad range of known mechanisms for pain transmission, numerous natural compounds of different origins are reported in the literature to directly or indirectly modulate pain transmission to produce analgesic effects. Most of these constituents modulate the release of endogenous analgesic mediators or inhibit algogenic neurotransmitters through pre- or post-synaptic mechanisms at both the central and peripheral levels.

2.7.1. Terpenes

Volatile Terpenes

Terpenes are a group of secondary metabolites with a great diversity of chemical structure. This type of compound comprises approximately 90% of the components of the essential oils of aromatic plants [116]. The essential oil of the species of the Lamiaceae is particularly rich in volatile monoterpenes, sesquiterpenes and diterpenes, which are made up of 10, 15 and 20 carbon atoms, respectively [1]. Terpenes are very diverse in both structure and function, but chemically they derive from the polymerization of isoprene; in fact, their classification is based on the number of isoprene units that bind to each other: hemi (one unit), mono (two units), sesqui (three units), di (four units), ses (five units), tetra (eight units), and polyterpenes (n-units). Monoterpenes, the main active ingredients in essential oils, consist of two isoprene units that are made up of five carbons joined [117].
Among the monoterpenes, the main reported compounds are α-pinene, β-pinene, 1,8-cineole, menthol, limonene, and γ-terpinene. The monoterpenes commonly present in the Lamiaceae family and whose antinociceptive, anti-inflammatory and/or antioxidant mechanisms of action have been evaluated, as well as their described chemical structure, are listed in Table 2. Anticancer, antimicrobial, antioxidant, antiviral, analgesic and anti-inflammatory activities are attributed to these compounds in various plant species [118]. Regarding the development of analgesics and anti-inflammatories, monoterpenes and sesquiterpenes have become a topic of interest with an increasing number of new patent applications [1,119,120,121]. According to some studies, monoterpenes are promising in the modulation of cytokines due to their lipophilic characteristics which favor their absorption and rapid action [121], and they have been recognized as stimulating an increase in anti-inflammatory cytokines, such as IL-10 [122,123]. Studies of Hyptis spicigera Lam. reported the antinociceptive effects of the essential oil because of the presence of α- and β-pinene, and 1,8-cineol associated to the participation of TRPV1, A1 and M8 receptors [58], whereas in the case of the essential oil of Monarda fistulosa L., carvacrol, thymol and β-myrcene were characterized as possible compounds responsible for the antinociceptive properties mediated by TRPA1 receptors [124]. The presence of δ-cadinene, α-pinene, myrcene, β-caryophylene, germacrene, and limonene in the essential oil of Teucrium stocksianum Boiss. was characterized as a bioactive antinociceptive in the writhing test [125] but also in the formalin test in the antinociceptive activity of Ocimum [126].

Non-Volatile Terpenes

Non-volatile diterpenes (made up 20 carbon atoms) and triterpenes (made up 30 carbon atoms) are reported as the two main subclasses of components of species in the Lamiaceae family [146]. Seven main types of non-volatile diterpenes have been reported differing in the various arrangements of the 20-carbon atom structure in order to form abietanes, clerodanes, ent-kauranes, iso-pimarans, labdanes and neo-clerodanes [117]. Some of these types are considered chemotaxonomic markers for specific subfamilies or genera [147], although all of them can be indifferently evidenced in all Lamiaceae species.
Much attention has recently been paid to diterpenoids such as marrubiin, from Marrubium vulgare L. assayed in experimental models of pain, such as writhing, formalin and hot-plate tests, but also carnosol and carnosic acid [148], which suppress cyclooxygenase (COX)-2, interleukin-1B, and TNF-alfa expression, as well as leukocyte infiltration in inflamed tissues [149,150].
Regarding triterpenes, two main types have been reported: pentacyclic triterpenes and phytoecdysteroids. The former is characterized by having an olean- and ursan-like base structure [151], with oleanolic acid and ursolic acid being the most reported pentacyclic triterpenes in species belonging to this family. Diterpenes and triterpenes within the Lamiaceae have also been reported to produce antinociceptive and/or anti-inflammatory effects. Their chemical structure and mechanism of action explored are listed in Table 3.

2.7.2. Phenolic Compounds

Some species of the Lamiaceae family and their biological activities have been characterized by the presence of phenolic compounds, even if only in minor quantities. Caffeic acid and rosmarinic acid, together with their derivatives, are the most reported phenolic acids in the family [170,171,172]. However, in recent studies, chemotaxonomic markers at the genera level have also been found [121].
In general terms, phenols and polyphenols refer to a group of plant secondary metabolites which carry at least one phenolic ring in their molecule; they are derived from shikimic acid and phenylpropanoid metabolism pathways. A phenolic ring is made up of a hydrophobic aromatic nucleus and a hydrophilic hydroxy group that can be involved in hydrogen bond formation. As redox active compounds, plant phenols can also act as antioxidants or pro-oxidants [173]. The antioxidant activity of phenolic compounds depends on the number of hydroxy substituents, their position and the site of binding on the aromatic ring [174].
All phenolic compounds of the plants in the Lamiaceae share significant antioxidant activity which is attributed to the complete extracts [175]. Antioxidants protect plant cells from damage caused by free radicals that develop with normal cellular metabolism or due to stressful events, such as excessive UV radiation, exposure to soil or air pollutants, and diseases [176]. The antioxidant properties of phenolic compounds can participate in the uptake of reactive oxygen species and reactive nitrogen species (ROS/RNS), inhibiting their formation by suppressing enzymes or metals associated with the production of free radicals, and regulating or defending the plant antioxidant systems [177].
Lipid peroxidation processes which cause damage to fatty acids tend to decrease membrane fluidity and lead to numerous pathological events [178], and could be reduced by phenolic acids in plants due to their capacity to modulate different oxygen species [121,175]. Furthermore, polyphenols have been demonstrated to protect the nervous system against oxidative stress, to such an extent that regular dietary intake of flavonoids has been associated with reduced dementia and delayed onset of Alzheimer’s and Parkinson’s diseases [179]. Polyphenols have been considered potential neuroprotective and direct neuromodulatory agents of the CNS because of their ability to cross the blood-brain barrier [180]. Plants belonging to the genera Calamintha, Lavandula, Mentha, Melissa, Origanum, Rosmarinus, Salvia, Teucrium or Thymus are used for the treatment of various nervous system disorders, mainly thanks to the presence of polyphenols, particularly rosmarinic acid [78].
Phenolic compounds present in the Lamiaceae and their corresponding structures, which have shown antioxidant, anti-inflammatory and/or antinociceptive pharmacological activity, related to the evaluated mechanisms of action, are shown in Table 4.

Phenolic Acids

Phenolic acids have been characterized as being responsible for the biological activity of several Lamiaceae species, such as antioxidant, anti-inflammatory and antinociceptive activities, exploring not only their pharmacological activity but also the possible mechanism of action involved (Table 4). As redox active compounds, phenolic acids can also act as antioxidants or pro-oxidants [173]. The antioxidant activity of phenolic compounds depends on the number of hydroxy substituents, their position and the site of binding on the aromatic ring [174]. Caffeic acid and rosmarinic acid and their derivatives have been part of the most common phenolic acids described [170,171,172]. Nevertheless, recent studies have found and established chemotaxonomic markers at the genera level [121].
Rosmarinic acid is among the main phenolic compounds contained in the tissues of various plant species belonging to this family. The genotype of the plant, but also physiological or environmental factors, such as phenology, climate, growth technique and stress conditions, strongly influence the amounts of phenolic compounds in the plant [121,196].
High levels of rosmarinic acid are commonly found only within the Nepetoideae subfamily. In the genus Stachys, in the Lamioideae subfamily [197], several species belonging to the Lamiaceae can accumulate high levels of different phenolic compounds, such as phenolic acids, flavonoids, or phenolic terpenes. Only in the Lamiaceae family are some phenolic compounds present, such as carnosic acid, which prevents the oxidative damage of the chloroplast and shows highly antioxidant properties in vitro [198]. Another phenolic acid exclusive to Lamiaceae species is clerodendranoic acid, which was found in Clerodendranthus spicatus (Thunb.) C.Y. Wu ex H.W. Li [199].

Flavonoids

A few compounds from flavonoid nature in Lamiaceae with antinociceptive and anti-inflammatory activities have been reported. This is the case of a standardized mixture of baicaline and catequine from Scutellaria baicalensis Georgi, which was evaluated using the writhing, formalin and carragennan tests in rodents [200]. Salvigenina was isolated from S. officinalis as the responsible flavonoid for the antinociceptive effects in writhing, hot-plate and carragennan tests [201]. Other flavonoids including pedalitin from S. amarissima have been explored in writhing test in mice [102], while tilianin and acacetin were identified in Agastache mexicana and reported in several experimental models of acute and chronic pain [113]. Examples of these flavonoids commonly present in species of the Lamiaceae family with antioxidant, antinociceptive and anti-inflammatory activity are listed in Table 5.

3. Materials and Methods

Literature Survey Databases

This literature review was carried out based on an electronic search in the Sciencedirect, Pubmed and Springer link databases in 2020. The keywords used were “Lamiaceae” “antinociceptive” “pain”, “analgesic” and “anti-inflammatory”. Almost 1200 articles were found, and after an extensive survey, 217 articles were selected, which described the antinociceptive and/or anti-inflammatory potential of natural compounds to relieve pain.

4. Conclusions

The chemical characteristics and the pharmacological properties of the Lamiaceae constituents are of interest to researchers, laboratories, and pharmaceutical companies. During the last few decades, the mechanisms of action of the different secondary metabolites of the Lamiaceae family have been broadly investigated by means of in vivo and in vitro assays to confirm their participation in the modulation of pain and in the cascade of inflammation mediators. This work summarizes part of the reported scientific knowledge regarding the secondary metabolites of some specific Mexican species of the Lamiaceae that have shown activity for pain relief, highlighting the participation of terpenes, flavonoids, and phenolic acids as potential alternatives for new drug therapies. As a result of this review, it is important to mention that few studies have been reported regarding Mexican genera of this family; for example, Calosphace is one of the largest subgenera of Salvia in all the world, mainly found in Mexico, but it has barely been investigated regarding its potential biological activities and their bioactive constituents. The scientific evidence regarding the different bioactive constituents found in species of the Lamiaceae family demonstrates that several species of this family require further investigation in preclinical studies, but also in controlled clinical trials to evaluate the efficacy and safety of these natural products to support their therapeutic potential in pain relief and/or inflammation, along with other health conditions.

Author Contributions

Conceptualization: M.E.G.-T., G.F.M.-P. and A.H.-L.; methodology, M.E.G.-T., G.F.M.-P., A.H.-L., M.G.V.-D., M.M.-G., E.A.-H. and M.I.D.-R.; validation, M.E.G.-T., G.F.M.-P., A.H.-L., M.M.-G., E.A.-H., M.I.D.-R. and F.P.; formal analysis, M.E.G.-T., G.F.M.-P., A.H.-L., M.M.-G. and E.A.-H.; investigation, M.E.G.-T., G.F.M.-P., A.H.-L., M.G.V.-D., M.M.-G., E.A.-H., M.I.D.-R. and F.P.; resources, M.E.G.-T., G.F.M.-P., A.H.-L., M.M.-G., E.A.-H. and F.P.; writing—original draft preparation, M.E.G.-T., G.F.M.-P., A.H.-L., M.G.V.-D., M.M.-G., E.A.-H., M.I.D.-R. and F.P.; writing—review and editing, M.E.G.-T., G.F.M.-P. and A.H.-L.; visualization, M.E.G.-T. and A.H.-L.; project administration, M.E.G.-T. and F.P. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially supported by Consejo Nacional de Ciencia y Tecnología (CONACYT) grant numbers 226454 and 256448 and Institutional projects numbers INP-NC123280.0 and INP-NC17073.0. G.F.M.-P thanks academic training and CONACYT Fellowship number 631351.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We thank to Psych. Marissa González for proof-reading the English version of this manuscript.

Conflicts of Interest

The authors declared no conflict of interest.

References

  1. Frezza, C.; Venditti, A.; Serafini, M.; Bianco, A. Phytochemistry, Chemotaxonomy, Ethnopharmacology, and Nutraceutics of Lamiaceae. Stud. Nat. Prod. Chem. 2019, 62, 125–178. [Google Scholar] [CrossRef]
  2. The Angiosperm Phylogeny Group; Chase, M.W.; Christenhusz, M.J.M.; Fay, M.F.; Byng, J.W.; Judd, W.S.; Soltis, D.E.; Mabberley, D.J.; Sennikov, A.N.; Soltis, P.S.; et al. An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG IV. Bot. J. Linn. Soc. 2016, 181, 1–20. [Google Scholar] [CrossRef] [Green Version]
  3. Harley, R.M.; Atkins, S.; Budantsev, A.L.; Cantino, P.D.; Conn, B.J.; Grayer, R.; Harley, M.M.; de Kok, R.; Krestovskaja, T.; Morales, R. Labiatae. In Flowering Plants · Dicotyledons; Springer: Berlin/Heidelberg, Germany, 2004; pp. 167–275. [Google Scholar] [CrossRef]
  4. Falcão, D.Q.; Fernandes, S.B.O.; Menezes, F.S. Triterpenos de Hyptis fasciculata Benth. Rev. Bras. Farmacogn. 2003, 13, 81–83. [Google Scholar] [CrossRef]
  5. Hossain, M.B.; Brunton, N.P.; Barry-Ryan, C.; Martin-Diana, A.B.; Wilkinson, M. Antioxidant activity of spice extracts and phenolics in comparison to synthetic antioxidants. Rasayan J. Chem. 2008, 1, 751–756. [Google Scholar] [CrossRef]
  6. Tajkarimi, M.M.; Ibrahim, S.A.; Cliver, D.O. Antimicrobial herb and spice compounds in food. Food Control 2010, 21, 1199–1218. [Google Scholar] [CrossRef]
  7. Astyrakaki, E.; Papaioannou, A.; Askitopoulou, H. References to anesthesia, pain, and analgesia in the Hippocratic collection. Anesth. Analg. 2010, 110, 188–194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Raja, S.N.; Carr, D.B.; Cohen, M.; Finnerup, N.B.; Flor, H.; Gibson, S.; Keefe, F.J.; Mogil, J.S.; Ringkamp, M.; Sluka, K.A.; et al. The revised IASP definition of pain: Concepts, challenges, and compromises. Pain 2020, 161, 1976–1983. [Google Scholar] [CrossRef] [PubMed]
  9. Orr, P.M.; Shank, B.C.; Black, A.C. The role of pain classification systems in pain management. Crit. Care Nurs. Clin. N. Am. 2017, 29, 407–418. [Google Scholar] [CrossRef]
  10. Ellison, D.L. Physiology of pain. Crit. Care Nurs. Clin. N. Am. 2017, 29, 397–406. [Google Scholar] [CrossRef] [PubMed]
  11. Woessner, J. Overview of pain: Classification and concepts. In Weiner’s Pain Management: A Practical Guide for Clinician; Boswell, M.V., Cole, B.E., Eds.; American Academy of Pain Management: Orlando, FL, USA, 2006; pp. 35–48. [Google Scholar]
  12. Armstrong, S.A.; Herr, M.J. Physiology Nociception; StatPearls, Ed.; StatPearls Publishing: Treasure Island, FL, USA, 2019; Available online: https://www.ncbi.nlm.nih.gov/books/NBK551562/ (accessed on 20 November 2021).
  13. Moehring, F.; Halder, P.; Seal, R.P.; Stucky, C.L. Uncovering the cells and circuits of touch in normal and pathological settings. Neuron 2018, 100, 349–360. [Google Scholar] [CrossRef] [Green Version]
  14. Rácz, I.; Zimmer, A. Animal Models of Nociception. Pharmacol. Rev. 2001, 53, 221–235. [Google Scholar] [CrossRef]
  15. Dray, A.; Perkins, M. Kinins and Pain. In Handbook of Immunopharmacology; Farmer, S.G., Ed.; Academic Press: London, UK, 1997; pp. 157–172. [Google Scholar] [CrossRef]
  16. Geppetti, P.; Nassini, R.; Materazzi, S.; Benemei, S. The concept of neurogenic inflammation. BJU Int. 2008, 101, 2–6. [Google Scholar] [CrossRef]
  17. Gordon, S.; Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5, 953–964. [Google Scholar] [CrossRef] [PubMed]
  18. Martinez, F.O.; Helming, L.; Gordon, S. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 2009, 27, 451–483. [Google Scholar] [CrossRef] [Green Version]
  19. Könner, A.C.; Brüning, J.C. Toll-like receptors: Linking inflammation to metabolism. Trends Endocrinol. Metab. 2011, 22, 16–23. [Google Scholar] [CrossRef] [PubMed]
  20. Lacagnina, M.J.; Watkins, L.R.; Grace, P.M. Toll-like receptors and their role in persistent pain. Pharmacol. Ther. 2018, 184, 145–158. [Google Scholar] [CrossRef]
  21. Roy, A.; Srivastava, M.; Saqib, U.; Liu, D.; Faisal, S.M.; Sugathan, S.; Bishnoi, S.; Baig, M.S. Potential therapeutic targets for inflammation in Toll-like receptor 4 (TLR4)-mediated signaling pathways. Int. Immunopharmacol. 2016, 40, 79–89. [Google Scholar] [CrossRef]
  22. Li, Q.; Verma, I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002, 2, 725–734. [Google Scholar] [CrossRef]
  23. Silverman, N.; Maniatis, T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001, 15, 2321–2342. [Google Scholar] [CrossRef] [Green Version]
  24. Jiang, P.Y.; Zhu, X.J.; Zhang, Y.N.; Zhou, F.F.; Yang, X.F. Protective effects of apigenin on LPS-induced endometritis via activating Nrf2 signaling pathway. Microb. Pathog. 2018, 123, 139–143. [Google Scholar] [CrossRef]
  25. Kyriakis, J.M.; Avruch, J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol. Rev. 2012, 92, 689–737. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Gurgis, F.M.S.; Ziaziaris, W.; Munoz, L. Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: Role and targeting. Mol. Pharmacol. 2014, 85, 345–356. [Google Scholar] [CrossRef] [Green Version]
  27. Kokkini, S.; Karousou, R.; Hanlidou, E. HERBS|Herbs of the Labiatae. In Encyclopedia of Food Sciences and Nutrition; Caballero, B., Ed.; Academic Press: Thessaloniki, Greece, 2003; pp. 3082–3090. [Google Scholar] [CrossRef]
  28. Martínez-Gordillo, M.; Fragoso-Martínez, I.; García-Peña, M.d.R.; Montiel, O. Géneros de Lamiaceae de México, diversidad y endemismo. Rev. Mex. Biodivers. 2013, 84, 30–86. [Google Scholar] [CrossRef] [Green Version]
  29. Bridi, H.; de Carvalho Meirelles, G.; Lino von Poser, G. Subtribe Hyptidinae (Lamiaceae): A promising source of bioactive metabolites. J. Ethnopharmacol. 2021, 264, 113225. [Google Scholar] [CrossRef]
  30. Hedge, I.C. A Global survey of the biogeography of the Labiatae. In Advances in Labiate Science; Harley, R.M., Reynolds, T., Eds.; Royal Botani Gardens, Kew: Richmond, UK, 1992; Volume 6, pp. 7–17. [Google Scholar]
  31. Li, B.; Olmstead, R.G. Two new subfamilies in Lamiaceae. Phytotaxa 2017, 313, 222–226. [Google Scholar] [CrossRef]
  32. Callmander, M.W.; Phillipson, P.B. New combinations and typifications in Vitex (Lamiaceae) from Madagascar. Candollea 2018, 73, 131–136. [Google Scholar] [CrossRef]
  33. Xi-wen, L.; Hedge, I.C. Lamiaceae Chun Xing Ke. Flora China 1994, 17, 50–299. [Google Scholar]
  34. Valverde, R.M. Labiates (Lamiaceae) of Chile. An. Jard. Bot. Madr. 2018, 75, e067. [Google Scholar] [CrossRef] [Green Version]
  35. Martínez-Gordillo, M.; Bedolla-García, B.; Cornejotenorio, G.; Fragoso-Martínez, I.; García-Peña, M.D.R.; González-Gallegos, J.G.; Lara-Cabrera, S.I.; Zamudio, S. Lamiaceae of Mexico. Bot. Sci. 2017, 95, 780–806. [Google Scholar] [CrossRef] [Green Version]
  36. González-Gallegos, J.G.; Bedolla-García, B.Y.; Cornejo-Tenorio, G.; Fernández-Alonso, J.L.; Fragoso-Martínez, I.; García-Peña, M.D.R.; Harley, R.M.; Klitgaard, B.; Martínez-Gordillo, M.J.; Wood, J.R.I.; et al. Richness and distribution of Salvia subg. Calosphace (Lamiaceae). Int. J. Plant Sci. 2020, 181, 831–856. [Google Scholar] [CrossRef]
  37. Li, B.; Cantino, P.D.; Olmstead, R.G.; Bramley, G.L.C.; Xiang, C.L.; Ma, Z.H.; Tan, Y.H.; Zhang, D.X. A large-scale chloroplast phylogeny of the Lamiaceae sheds new light on its subfamilial classification. Sci. Rep. 2016, 6, 34343. [Google Scholar] [CrossRef] [Green Version]
  38. Hanlidou, E.; Karousou, R.; Kleftoyanni, V.; Kokkini, S. The herbal market of Thessaloniki (N Greece) and its relation to the ethnobotanical tradition. J. Ethnopharmacol. 2004, 91, 281–299. [Google Scholar] [CrossRef] [PubMed]
  39. Kleftoyanni, V.; Kokkini, S. The Labiatae plants used traditionally in Thessaloniki. Bocconea 2003, 16, 1117–1121. [Google Scholar]
  40. Uritu, C.M.; Mihai, C.T.; Stanciu, G.D.; Dodi, G.; Alexa-Stratulat, T.; Luca, A.; Leon-Constantin, M.M.; Stefanescu, R.; Bild, V.; Melnic, S.; et al. Medicinal plants of the family Lamiaceae in pain therapy: A review. Pain Res. Manag. 2018, 2018, 7801543. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Aćimović, M.; Jeremić, K.; Salaj, N.; Gavarić, N.; Kiprovski, B.; Sikora, V.; Zeremski, T. Marrubium vulgare L.: A phytochemical and pharmacological overview. Molecules 2020, 25, 2898. [Google Scholar] [CrossRef]
  42. Kahkeshani, N.; Gharedaghi, M.; Hadjiakhoondi, A.; Sharifzadeh, M.; Khanavi, M. Antinociceptive effect of extracts of Marrubium astracanicum Jacq. aerial parts. Avicenna J. Phytomed. 2017, 7, 73–79. [Google Scholar] [CrossRef] [PubMed]
  43. De Lima, A.C.B.; Paixão, M.S.; Melo, M.; Santana, M.T.D.; Damascena, N.P.; Dias, A.S.; Porto, Y.C.B.S.; Fernandes, X.A.; Santos, C.C.S.; Lima, C.A.; et al. Orofacial antinociceptive effect and antioxidant properties of the hydroethanol extract of Hyptis fruticosa salmz ex Benth. J. Ethnopharmacol. 2013, 146, 192–197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Dos Anjos, K.S.; Araújo-Filho, H.G.; Duarte, M.C.; Costa, V.C.O.; Tavares, J.F.; Silva, M.S.; Almeida, J.R.G.S.; Souza, N.A.C.; Rolim, L.A.; Menezes, I.R.A.; et al. HPLC-DAD analysis, antinociceptive and anti-inflammatory properties of the ethanolic extract of Hyptis umbrosa in mice. EXCLI J. 2017, 14, 14–24. [Google Scholar] [CrossRef]
  45. Arzi, A.; Namjouyan, F.; Sarahoodi, S.; Khorasgani, Z.N.; Macvandi, E. The study of antinociceptive effect of hydroalcoholic extract of Teucrium oliverianum (A plant use in Southern Iranian traditional medicine) in rat by formalin test. Pak. J. Biol. Sci. 2011, 14, 1066–1069. [Google Scholar] [CrossRef]
  46. Miri, A.; Sharifi-Rad, J.; Tabrizian, K.; Nasiri, A.A. Antinociceptive and anti-inflammatory activities of Teucrium persicum Boiss. extract in mice. Scientifica 2015, 2015, 972827. [Google Scholar] [CrossRef] [Green Version]
  47. Shah, S.M.M.; Shah, S.M.H. Phytochemicals, antioxidant, antinociceptive and anti-inflammatory potential of the aqueous extract of Teucrium stocksianum bioss. BMC Complement. Altern. Med. 2015, 15, 351. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Zhou, J.; Qu, F.; Zhang, H.J.; Zhuge, X.H.; Cheng, L.Z. Comparison of anti-inflammatory and anti-nociceptive activities of Curcuma wenyujin Y.H. Chen et C. Ling and Scutellaria baicalensis Georgi. Afr. J. Tradit. Complement. Altern. Med. 2010, 7, 339–349. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Rezaee-Asl, M.; Sabour, M.; Nikoui, V.; Ostadhadi, S.; Bakhtiarian, A. The study of analgesic effects of Leonurus cardiaca L. in mice by formalin, tail flick and hot plate tests. Int. Sch. Res. Not. 2014, 2014, 687697. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Amirova, K.M.; Dimitrova, P.; Marchev, A.S.; Aneva, I.Y.; Georgiev, M.I. Clinopodium vulgare L. (wild basil) extract and its active constituents modulate cyclooxygenase-2 expression in neutrophils. Food Chem. Toxicol. 2019, 124, 1–9. [Google Scholar] [CrossRef]
  51. Estrada-Reyes, R.; Martínez-Vázquez, M.; Gallegos-Solís, A.; Heinze, G.; Moreno, J. Depressant effects of Clinopodium mexicanum Benth. Govaerts (Lamiaceae) on the central nervous system. J. Ethnopharmacol. 2010, 130, 1–8. [Google Scholar] [CrossRef]
  52. Bajalan, I.; Zand, M.; Goodarzi, M.; Darabi, M. Antioxidant activity and total phenolic and flavonoid content of the extract and chemical composition of the essential oil of Eremostachys laciniata collected from Zagros. Asian Pac. J. Trop. Biomed. 2017, 7, 144–146. [Google Scholar] [CrossRef]
  53. Zhu, Q.-F.; Wang, Y.-Y.; Jiang, W.; Qu, H.-B. Three new norlignans from Glechoma longituba. J. Asian Nat. Prod. Res. 2013, 15, 258–264. [Google Scholar] [CrossRef]
  54. Viveros-Valdez, E.; Rivas-Morales, C.; Carranza-Rosales, P.; Mendoza, S.; Schmeda-Hirschmann, G. Free Radical Scavengers from the Mexican Herbal Tea “Poleo” (Hedeoma drummondii). Z. Naturforsch. Sect. C J. Biosci. 2008, 63, 341–346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Dadé, M.M.; Schinella, G.R.; Fioravanti, D.E.; Alfiotournier, H. Antioxidant and cytotoxic properties of an aqueous extract from the Argentinean plant Hedeoma multiflorum. Pharm. Biol. 2011, 49, 633–639. [Google Scholar] [CrossRef]
  56. Pal, M.; Singh, M.; Chaudhuri, P.K.; Sharma, R.P.; Singh, N. Antiinflammatory activity of Holmskioldia sanguinea extracts. Phyther. Res. 1996, 10, 357–358. [Google Scholar] [CrossRef]
  57. Begum, A.; Sama, V.; Dodle, J.P. Study of antinociceptive effects on acute pain treated by bioactive fractions of Hyptis suaveolens. J. Acute Dis. 2016, 5, 397–401. [Google Scholar] [CrossRef] [Green Version]
  58. Simões, R.R.; Coelho, I.d.S.; Junqueira, S.C.; Pigatto, G.R.; Salvador, M.J.; Santos, A.R.S.; de Faria, F.M. Oral treatment with essential oil of Hyptis spicigera Lam. (Lamiaceae) reduces acute pain and inflammation in mice: Potential interactions with transient receptor potential (TRP) ion channels. J. Ethnopharmacol. 2017, 200, 8–15. [Google Scholar] [CrossRef]
  59. Trouillas, P.; Calliste, C.A.; Allais, D.P.; Simon, A.; Marfak, A.; Delage, C.; Duroux, J.L. Antioxidant, anti-inflammatory and antiproliferative properties of sixteen water plant extracts used in the Limousin countryside as herbal teas. Food Chem. 2003, 80, 399–407. [Google Scholar] [CrossRef]
  60. Hajhashemi, V.; Ghannadi, A.; Sharif, B. Anti-inflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill. J. Ethnopharmacol. 2003, 89, 67–71. [Google Scholar] [CrossRef]
  61. Blažeković, B.; Vladimir-Knežević, S.; Brantner, A.; Štefan, M.B. Evaluation of antioxidant potential of Lavandula x intermedia Emeric ex Loisel. “Budrovka”: A comparative study with L. angustifolia Mill. Molecules 2010, 15, 5971–5987. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Wojtyniak, K.; Szymański, M.; Matławska, I. Leonurus cardiaca L. (Motherwort): A review of its phytochemistry and pharmacology. Phyther. Res. 2013, 27, 1115–1120. [Google Scholar] [CrossRef]
  63. El-Ansari, M.A.; Aboutabl, E.A.; Farrag, A.R.H.; Sharaf, M.; Hawas, U.W.; Soliman, G.M.; El-Seed, G.S. Phytochemical and pharmacological studies on Leonotis leonurus. Pharm. Biol. 2009, 47, 894–902. [Google Scholar] [CrossRef] [Green Version]
  64. Rahman, M.S.; Sadhu, S.K.; Hasan, C.M. Preliminary antinociceptive, antioxidant and cytotoxic activities of Leucas aspera root. Fitoterapia 2007, 78, 552–555. [Google Scholar] [CrossRef]
  65. Meyre-Silva, C.; Cechinel-Filho, V. A Review of the Chemical and Pharmacological Aspects of the Genus Marrubium. Curr. Pharm. Des. 2010, 16, 3503–3518. [Google Scholar] [CrossRef]
  66. Sun, Z.; Wang, H.; Wang, J.; Zhou, L.; Yang, P. Chemical composition and anti-inflammatory, cytotoxic and antioxidant activities of essential oil from leaves of Mentha piperita grown in China. PLoS ONE 2014, 9, e0114767. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Moreno, L.; Bello, R.; Primo-Yúfera, E.; Esplugues, J. Pharmacological properties of the methanol extract from Mentha suaveolens Ehrh. Phyther. Res. 2002, 16, 10–13. [Google Scholar] [CrossRef]
  68. Trakoontivakorn, G.; Tangkanakul, P.; Nakahara, K. Changes of antioxidant capacity and phenolics in Ocimum herbs after various cooking methods. Jpn. Agric. Res. Q. 2012, 46, 347–353. [Google Scholar] [CrossRef] [Green Version]
  69. Bae, A.H.; Kim, G.; Seol, G.H.; Lee, S.B.; Lee, J.M.; Chang, W.; Min, S.S. Delta- and mu-opioid pathways are involved in the analgesic effect of Ocimum basilicum L in mice. J. Ethnopharmacol. 2020, 250, 112471. [Google Scholar] [CrossRef] [PubMed]
  70. Algieri, F.; Zorrilla, P.; Rodriguez-Nogales, A.; Garrido-Mesa, N.; Bañuelos, Ó.; González-Tejero, M.R.; Casares-Porcel, M.; Molero-Mesa, J.; Zarzuelo, A.; Utrilla, M.P.; et al. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis. J. Ethnopharmacol. 2013, 146, 750–759. [Google Scholar] [CrossRef] [PubMed]
  71. Sarikurkcu, C.; Uren, M.C.; Tepe, B.; Cengiz, M.; Kocak, M.S. Phenolic content, enzyme inhibitory and antioxidative activity potentials of Phlomis nissolii and P. pungens var. pungens. Ind. Crop. Prod. 2014, 62, 333–340. [Google Scholar] [CrossRef]
  72. Narayanan, N.; Thirugnanasambantham, P.; Viswanathan, S.; Reddy, M.K.; Vijayasekaran, V.; Sukumar, E. Antipyretic, antinociceptive and anti-inflammatory activity of Premna herbacea roots. Fitoterapia 2000, 71, 147–153. [Google Scholar] [CrossRef]
  73. Azad, R.; Babu, N.K.; Gupta, A.D.; Reddanna, P. Evaluation of anti-inflammatory and immunomodulatory effects of Premna integrifolia extracts and assay-guided isolation of a COX-2/5-LOX dual inhibitor. Fitoterapia 2018, 131, 189–199. [Google Scholar] [CrossRef] [PubMed]
  74. Raafat, K.; Wurglics, M.; Schubert-Zsilavecz, M. Prunella vulgaris L. active components and their hypoglycemic and antinociceptive effects in alloxan-induced diabetic mice. Biomed. Pharmacother. 2016, 84, 1008–1018. [Google Scholar] [CrossRef]
  75. Erkan, N.; Ayranci, G.; Ayranci, E. Antioxidant activities of rosemary (Rosmarinus Officinalis L.) extract, blackseed (Nigella sativa L.) essential oil, carnosic acid, rosmarinic acid and sesamol. Food Chem. 2008, 110, 76–82. [Google Scholar] [CrossRef]
  76. Martínez, A.L.; González-Trujano, M.E.; Chávez, M.; Pellicer, F. Antinociceptive effectiveness of triterpenes from rosemary in visceral nociception. J. Ethnopharmacol. 2012, 142, 28–34. [Google Scholar] [CrossRef]
  77. Imanshahidi, M.; Hosseinzadeh, H. The pharmacological effects of Salvia species on the central nervous system. Phyther. Res. 2006, 20, 427–437. [Google Scholar] [CrossRef] [PubMed]
  78. Vladimir-Knezevic, S.; Blazekovic, B.; Kindl, M.; Vladic, J.; Lower-Nedza, A.D.; Brantner, A.H. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the lamiaceae family. Molecules 2014, 19, 767–782. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Rodrigues, M.R.A.; Kanazawa, L.K.S.; Neves, T.L.M.H.D.; Silva, C.F.D.; Horst, H.; Pizzolatti, M.G.; Santos, A.R.S.; Baggio, C.H.; Werner, M.F.D.P. Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice. J. Ethnopharmacol. 2012, 139, 519–526. [Google Scholar] [CrossRef]
  80. Fan, M.; Luo, D.; Peng, L.Y.; Li, X.N.; Wu, X.D.; Ji, X.; Zhao, Q.S. Neo-clerodane diterpenoids from aerial parts of Salvia hispanica L. and their cardioprotective effects. Phytochemistry 2019, 166, 112065. [Google Scholar] [CrossRef] [PubMed]
  81. Cuong, T.D.; Hung, T.M.; Lee, J.S.; Weon, K.Y.; Woo, M.H.; Min, B.S. Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica. Bioorg. Med. Chem. Lett. 2015, 25, 1129–1134. [Google Scholar] [CrossRef] [PubMed]
  82. EghbaliFeriz, S.; Taleghani, A.; Tayarani-Najaran, Z. Central nervous system diseases and Scutellaria: A review of current mechanism studies. Biomed. Pharmacother. 2018, 102, 185–195. [Google Scholar] [CrossRef]
  83. Cavalcanti, M.R.M.; Passos, F.R.S.; Monteiro, B.S.; Gandhi, S.R.; Heimfarth, L.; Lima, B.S.; Nascimento, Y.M.; Duarte, M.C.; Araujo, A.A.S.; Menezes, I.R.A.; et al. HPLC-DAD-UV analysis, anti-inflammatory and anti-neuropathic effects of methanolic extract of Sideritis bilgeriana (lamiaceae) by NF-κB, TNF-α, IL-1β and IL-6 involvement. J. Ethnopharmacol. 2021, 265, 113338. [Google Scholar] [CrossRef]
  84. Bardakci, H.; Cevik, D.; Barak, T.H.; Gozet, T.; Kan, Y.; Kirmizibekmez, H. Secondary metabolites, phytochemical characterization and antioxidant activities of different extracts of Sideritis congesta P.H. Davis et Hub.-Mor. Biochem. Syst. Ecol. 2020, 92, 104120. [Google Scholar] [CrossRef]
  85. Khanavi, M.; Sharifzadeh, M.; Hadjiakhoondi, A.; Shafiee, A. Phytochemical investigation and anti-inflammatory activity of aerial parts of Stachys byzanthina C. Koch. J. Ethnopharmacol. 2005, 97, 463–468. [Google Scholar] [CrossRef]
  86. Maleki, N.; Garjani, A.; Nazemiyeh, H.; Nilfouroushan, N.; Eftekhar Sadat, A.T.; Allameh, Z.; Hasannia, N. Potent anti-inflammatory activities of hydroalcoholic extract from aerial parts of Stachys inflata on rats. J. Ethnopharmacol. 2001, 75, 213–218. [Google Scholar] [CrossRef]
  87. Nikolić, M.; Glamočlija, J.; Ferreira, I.C.F.R.; Calhelha, R.C.; Fernandes, Â.; Marković, T.; Marković, D.; Giweli, A.; Soković, M. Chemical composition, antimicrobial, antioxidant and antitumor activity of Thymus serpyllum L., Thymus algeriensis Boiss. and Reut and Thymus vulgaris L. essential oils. Ind. Crop. Prod. 2014, 52, 183–190. [Google Scholar] [CrossRef]
  88. Reddy, V.P.; Vital, K.R.; Varsha, P.; Satyam, S. Review on Thymus vulgaris traditional uses and pharmacological properties. Med. Aromat. Plants 2014, 3, 167. [Google Scholar] [CrossRef] [Green Version]
  89. Chan, E.W.C.; Wong, S.K.; Chan, H.T. Casticin from Vitex species: A short review on its anticancer and anti-inflammatory properties. J. Integr. Med. 2018, 16, 147–152. [Google Scholar] [CrossRef] [PubMed]
  90. Hamann, F.R.; Zago, A.M.; Rossato, M.F.; Beck, V.R.; Mello, C.F.; de Brum, T.F.; de Carvalho, L.M.; Faccin, H.; Oliveira, S.M.; Rubin, M.A. Antinociceptive and antidepressant-like effects of the crude extract of Vitex megapotamica in rats. J. Ethnopharmacol. 2016, 192, 210–216. [Google Scholar] [CrossRef] [PubMed]
  91. Baricevic, D.; Sosa, S.; Della Loggia, R.; Tubaro, A.; Simonovska, B.; Krasna, A.; Zupancic, A. Topical anti-inflammatory activity of Salvia officinalis L. leaves: The relevance of ursolic acid. J. Ethnopharmacol. 2001, 75, 125–132. [Google Scholar] [CrossRef]
  92. Jurca, T.; Baldea, I.; Filip, G.A.; Olteanu, D.; Clichici, S.; Pallag, A.; Vicaş, L.; Marian, E.; Micle, O.; Crivii, C.B.; et al. A phytocomplex consisting of Tropaeolum majus L. and Salvia officinalis L. extracts alleviate the inflammatory response of dermal fibroblasts to bacterial lipopolysaccharides. Oxid. Med. Cell. Longev. 2020, 2020, 8516153. [Google Scholar] [CrossRef] [PubMed]
  93. Gonzalez-Trujano, M.E.; Pena, E.I.; Martinez, A.L.; Moreno, J.; Guevara-Fefer, P.; Deciga-Campos, M.; Lopez-Munoz, F.J. Evaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodents. J. Ethnopharmacol. 2007, 111, 476–482. [Google Scholar] [CrossRef]
  94. Martinez, A.L.; Gonzalez-Trujano, M.E.; Chavez, M.; Pellicer, F.; Moreno, J.; Lopez-Munoz, F.J. Hesperidin produces antinociceptive response and synergistic interaction with ketorolac in an arthritic gout-type pain in rats. Pharmacol. Biochem. Behav. 2011, 97, 683–689. [Google Scholar] [CrossRef]
  95. Ventura-Martínez, R.; Rivero-Osorno, O.; Gómez, C.; González-Trujano, M.E. Spasmolytic activity of Rosmarinus officinalis L. involves calcium channels in the guinea pig ileum. J. Ethnopharmacol. 2011, 137, 1528–1532. [Google Scholar] [CrossRef] [PubMed]
  96. Beltrán-Villalobos, K.L.; Déciga-Campos, M.; Aguilar-Mariscal, H.; González-Trujano, M.E.; Martínez-Salazar, M.F.; Ramírez-Cisneros, M.d.l.Á.; Rios, M.Y.; López-Muñoz, F.J. Synergistic antinociceptive interaction of Syzygium aromaticum or Rosmarinus officinalis coadministered with ketorolac in rats. Biomed. Pharmacother. 2017, 94, 858–864. [Google Scholar] [CrossRef]
  97. Cunningham, C.W.; Rothman, R.B.; Prisinzano, T.E. Neuropharmacology of the naturally occurring κ-opioid hallucinogen salvinorin A. Pharmacol. Rev. 2011, 63, 316–347. [Google Scholar] [CrossRef] [Green Version]
  98. Tlacomulco-Flores, L.L.; Déciga-Campos, M.; González-Trujano, M.E.; Carballo-Villalobos, A.I.; Pellicer, F. Antinociceptive effects of Salvia divinorum and bioactive salvinorins in experimental pain models in mice. J. Ethnopharmacol. 2020, 248, 112276. [Google Scholar] [CrossRef] [PubMed]
  99. Simón-Arceo, K.; González-Trujano, M.E.; Coffeen, U.; Fernández-Mas, R.; Mercado, F.; Almanza, A.; Contreras, B.; Jaimes, O.; Pellicer, F. Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats. J. Ethnopharmacol. 2017, 206, 115–124. [Google Scholar] [CrossRef] [PubMed]
  100. Guida, F.; Luongo, L.; Aviello, G.; Palazzo, E.; De Chiaro, M.; Gatta, L.; Boccella, S.; Marabese, I.; Zjawiony, J.K.; Capasso, R.; et al. Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. Mol. Pain 2012, 8, 1–14. [Google Scholar] [CrossRef] [Green Version]
  101. Coffeen, U.; Canseco-Alba, A.; Simón-Arceo, K.; Almanza, A.; Mercado, F.; León-Olea, M.; Pellicer, F. Salvinorin A reduces neuropathic nociception in the insular cortex of the rat. Eur. J. Pain 2018, 22, 311–318. [Google Scholar] [CrossRef] [PubMed]
  102. Moreno-Pérez, G.F.; González-Trujano, M.E.; Martínez-Gordillo, M.J.; Miguel-Chávez, R.S.; Basurto-Peña, F.A.; Dorazco-González, A.; Aguirre-Hernández, E. Amarisolide A and pedalitin as bioactive compounds in the antinociceptive effects of Salvia circinata (Lamiaceae). Bot. Sci. 2019, 97, 355–365. [Google Scholar] [CrossRef]
  103. Moreno-Pérez, F.; Hernandez-Leon, A.; Valle Dorado, M.G.; Cano Martínez, A.; Narváez-González, F.; Aguirre Hernández, E.; Salgado-Ceballos, H.; González-Trujano, M.E. Neo-clerodane diterpenic influence in the antinociceptive and anti-inflammatory properties of Salvia circinnata Cav. J. Ethnopharmacol. 2021, 268, 113550. [Google Scholar] [CrossRef]
  104. Flores-Bocanegra, L.; González-Andrade, M.; Bye, R.; Linares, E.; Mata, R. α-glucosidase inhibitors from Salvia circinata. J. Nat. Prod. 2017, 80, 1584–1593. [Google Scholar] [CrossRef]
  105. Salinas-Arellano, E.; Pérez-Vásquez, A.; Rivero-Cruz, I.; Torres-Colin, R.; González-Andrade, M.; Rangel-Grimaldo, M.; Mata, R. Flavonoids and terpenoids with PTP-1B inhibitory properties from the infusion of Salvia amarissima ortega. Molecules 2020, 25, 3530. [Google Scholar] [CrossRef] [PubMed]
  106. Hernandez-Leon, A.; Fernández-Guasti, A.; González-Trujano, M.E. Rutin antinociception involves opioidergic mechanism and descending modulation of ventrolateral periaqueductal grey matter in rats. Eur. J. Pain 2016, 20, 274–283. [Google Scholar] [CrossRef]
  107. Hernandez-Leon, A.; González-Trujano, M.E.; Fernández-Guasti, A. The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala. Behav. Pharmacol. 2017, 28, 303–312. [Google Scholar] [CrossRef]
  108. Bautista, E.; Fragoso-Serrano, M.; Ortiz-Pastrana, N.; Toscano, R.A.; Ortega, A. Structural elucidation and evaluation of multidrug-resistance modulatory capability of amarissinins A–C, diterpenes derived from Salvia amarissima. Fitoterapia 2016, 114, 1–6. [Google Scholar] [CrossRef]
  109. Ortiz-Mendoza, N.; Zavala-Ocampo, L.M.; Martínez-Gordillo, M.J.; González-Trujano, M.E.; Peña, F.A.B.; Bazany-Rodríguez, I.J.; Chávez, J.A.R.; Dorazco-González, A.; Aguirre-Hernández, E. Antinociceptive and anxiolytic-like effects of a neo-clerodane diterpene from Salvia semiatrata aerial parts. Pharm. Biol. 2020, 58, 620–629. [Google Scholar] [CrossRef]
  110. Weisenberg, M. Cognitive aspects of pain. In Wall & Melzack’s Textbook of Pain; Wall, P.D., Melzack, R., Eds.; Churchill-Livingstone: London, UK, 1984; p. 1588. [Google Scholar]
  111. Estrada-Reyes, R.; López-Rubalcava, C.; Ferreyra-Cruz, O.A.; Dorantes-Barrón, A.M.; Heinze, G.; Moreno Aguilar, J.; Martínez-Vázquez, M. Central nervous system effects and chemical composition of two subspecies of Agastache mexicana; An ethnomedicine of Mexico. J. Ethnopharmacol. 2014, 153, 98–110. [Google Scholar] [CrossRef]
  112. González-Trujano, M.E.; Ventura-Martínez, R.; Chávez, M.; Díaz-Reval, I.; Pellicer, F. Spasmolytic and antinociceptive activities of ursolic acid and acacetin identified in Agastache mexicana. Planta Med. 2012, 78, 793–796. [Google Scholar] [CrossRef] [PubMed]
  113. Ventura-Martínez, R.; Rodríguez, R.; González-Trujano, M.E.; Ángeles-López, G.E.; Déciga-Campos, M.; Gómez, C. Spasmogenic and spasmolytic activities of Agastache mexicana ssp. mexicana and A. mexicana ssp. xolocotziana methanolic extracts on the guinea pig ileum. J. Ethnopharmacol. 2017, 196, 58–65. [Google Scholar] [CrossRef]
  114. González-Ramírez, A.E.; González-Trujano, M.E.; Pellicer, F.; López-Muñoz, F.J. Anti-nociceptive and anti-inflammatory activities of the Agastache mexicana extracts by using several experimental models in rodents. J. Ethnopharmacol. 2012, 142, 700–705. [Google Scholar] [CrossRef] [PubMed]
  115. Verano, J.; González-Trujano, M.E.; Déciga-Campos, M.; Ventura-Martínez, R.; Pellicer, F. Ursolic acid from Agastache mexicana aerial parts produces antinociceptive activity involving TRPV1 receptors, cGMP and a serotonergic synergism. Pharmacol. Biochem. Behav. 2013, 110, 255–264. [Google Scholar] [CrossRef] [PubMed]
  116. Dhifi, W.; Bellili, S.; Jazi, S.; Bahloul, N.; Mnif, W. Essential oils’ chemical characterization and investigation of some biological activities: A critical review. Medicines 2016, 4, 25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Wang, G.; Tang, W.; Bidigare, R.R. Terpenoids as therapeutic drugs and pharmaceutical agents. In Natural Products: Drug Discovery and Therapeutic Medicine; Zhang, L., Demian, A.L., Eds.; Humana Press: Totowa, NJ, USA, 2005; pp. 197–227. [Google Scholar] [CrossRef]
  118. Sharmeen, J.B.; Shanoo, S.; Rengasamy Kannan, R.R.; Fawzi, M.M. Chemistry, bioactivities, mode of action and industrial applications of essential oils. Trends Food Sci. Technol. 2020, 101, 89–105. [Google Scholar] [CrossRef]
  119. Bernstein, N.; Akram, M.; Daniyal, M.; Koltai, H.; Fridlender, M.; Gorelick, J. Antiinflammatory potential of medicinal plants: A source for therapeutic secondary metabolites. In Advances in Agronomy; Academic Press Inc.: Cambridge, MA, USA, 2018; pp. 131–183. [Google Scholar] [CrossRef]
  120. Salehi, B.; Valussi, M.; Jugran, A.K.; Martorell, M.; Ramírez-Alarcón, K.; Stojanović-Radić, Z.Z.; Antolak, H.; Kręgiel, D.; Mileski, K.S.; Sharifi-Rad, M.; et al. Nepeta species: From farm to food applications and phytotherapy. Trends Food Sci. Technol. 2018, 80, 104–122. [Google Scholar] [CrossRef]
  121. Trivellini, A.; Lucchesini, M.; Maggini, R.; Mosadegh, H.; Villamarin, T.S.S.; Vernieri, P.; Mensuali-Sodi, A.; Pardossi, A. Lamiaceae phenols as multifaceted compounds: Bioactivity, industrial prospects and role of “positive-stress”. Ind. Crop. Prod. 2016, 83, 241–254. [Google Scholar] [CrossRef]
  122. De Souza Siqueira, Q.J.; Menezes, P.P.; Santos, M.R.V.; Bonjardim, L.R.; Almeida, J.R.G.S.; Gelain, D.P.; Araújo, A.A.D.S.; Quintans, L.J. Improvement of p-cymene antinociceptive and anti-inflammatory effects by inclusion in β-cyclodextrin. Phytomedicine 2013, 20, 436–440. [Google Scholar] [CrossRef] [Green Version]
  123. Quintans, J.S.S.; Shanmugam, S.; Heimfarth, L.; Araújo, A.A.S.; Almeida, J.R.G.d.S.; Picot, L.; Quintans-Júnior, L.J. Monoterpenes modulating cytokines—A review. Food Chem. Toxicol. 2019, 123, 233–257. [Google Scholar] [CrossRef]
  124. Ghosh, M.; Schepetkin, I.A.; Özek, G.; Özek, T.; Khlebnikov, A.I.; Damron, D.S.; Quinn, M.T. Essential oils from Monarda fistulosa: Chemical composition and activation of transient receptor potential A1 (TRPA1) channels. Molecules 2020, 25, 4873. [Google Scholar] [CrossRef] [PubMed]
  125. Shah, S.M.M.; Ullah, F.; Shah, S.M.H.; Zahoor, M.; Sadiq, A. Analysis of chemical constituents and antinociceptive potential of essential oil of Teucrium Stocksianum bioss collected from the North West of Pakistan. BMC Complement. Altern. Med. 2012, 12, 244. [Google Scholar] [CrossRef] [Green Version]
  126. Rabelo, M.; Souza, E.P.; Soares, P.M.G.; Miranda, A.V.; Matos, F.J.A.; Criddle, D.N. Antinociceptive properties of the essential oil of Ocimum gratissimum L. (Labiatae) in mice. Braz. J. Med. Biol. Res. 2003, 36, 521–524. [Google Scholar] [CrossRef] [PubMed]
  127. Kim, D.S.; Lee, H.J.; Jeon, Y.D.; Han, Y.H.; Kee, J.Y.; Kim, H.J.; Shin, H.J.; Kang, J.; Lee, B.S.; Kim, S.H.; et al. Alpha-pinene exhibits anti-Inflammatory activity through the suppression of MAPKs and the NF-κB pathway in mouse peritoneal macrophages. Am. J. Chin. Med. 2015, 43, 731–742. [Google Scholar] [CrossRef]
  128. Li, X.J.; Yang, Y.J.; Li, Y.S.; Zhang, W.K.; Tang, H.B. α-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2. J. Ethnopharmacol. 2016, 179, 22–26. [Google Scholar] [CrossRef]
  129. Kummer, R.; Fachini-Queiroz, F.C.; Estevão-Silva, C.F.; Grespan, R.; Silva, E.L.; Bersani-Amado, C.A.; Cuman, R.K.N. Evaluation of anti-inflammatory activity of Citrus latifolia Tanaka essential oil and limonene in experimental mouse models. Evid.-Based Complement. Altern. Med. 2013, 2013, 859083. [Google Scholar] [CrossRef] [Green Version]
  130. Yoon, W.-J.; Lee, N.H.; Hyun, C.-G. Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 264.7 macrophages. J. Oleo Sci. 2010, 59, 415–421. [Google Scholar] [CrossRef] [Green Version]
  131. Batista, P.A.; De Paula Werner, M.F.; Oliveira, E.C.; Burgos, L.; Pereira, P.; Da Silva Brum, L.F.; Story, G.M.; Santos, A.R.S. The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. J. Pain 2010, 11, 1222–1229. [Google Scholar] [CrossRef] [PubMed]
  132. Deepa, B.; Anuradha, C.V. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats. Toxicol. Mech. Methods 2013, 23, 223–234. [Google Scholar] [CrossRef] [PubMed]
  133. Peana, A.T.; D’Aquila, P.S.; Chessa, M.L.; Moretti, M.D.L.; Serra, G.; Pippia, P. (-)-Linalool produces antinociception in two experimental models of pain. Eur. J. Pharmacol. 2003, 460, 37–41. [Google Scholar] [CrossRef]
  134. Rao, V.S.N.; Menezes, A.M.S.; Viana, G.S.B. Effect of myrcene on nociception in mice. J. Pharm. Pharmacol. 1990, 42, 877–878. [Google Scholar] [CrossRef] [PubMed]
  135. Rufino, A.T.; Ribeiro, M.; Sousa, C.; Judas, F.; Salgueiro, L.; Cavaleiro, C.; Mendes, A.F. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur. J. Pharmacol. 2015, 750, 141–150. [Google Scholar] [CrossRef] [PubMed]
  136. De Santana, M.F.; Guimarães, A.G.; Chaves, D.O.; Silva, J.C.; Bonjardim, L.R.; Lucca Júnior, W.; de Ferro, J.N.d.S.; Barreto, E.d.O.; Santos, F.E.; dos Soares, M.B.P.; et al. The anti-hyperalgesic and anti-inflammatory profiles of p -cymene: Evidence for the involvement of opioid system and cytokines. Pharm. Biol. 2015, 53, 1583–1590. [Google Scholar] [CrossRef]
  137. Santos, W.B.R.; Melo, M.A.O.; Alves, R.S.; de Brito, R.G.; Rabelo, T.K.; Prado, L.d.S.; Silva, V.K.d.S.; Bezerra, D.P.; de Menezes-Filho, J.E.R.; Souza, D.S.; et al. p-Cymene attenuates cancer pain via inhibitory pathways and modulation of calcium currents. Phytomedicine 2019, 61, 152836. [Google Scholar] [CrossRef]
  138. Haeseler, G.; Maue, D.; Grosskreutz, J.; Bufler, J.; Nentwig, B.; Piepenbrock, S.; Dengler, R.; Leuwer, M. Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol. Eur. J. Anaesthesiol. 2002, 19, 571–579. [Google Scholar] [CrossRef]
  139. Xu, Z.H.; Wang, C.; Fujita, T.; Jiang, C.Y.; Kumamoto, E. Action of thymol on spontaneous excitatory transmission in adult rat spinal substantia gelatinosa neurons. Neurosci. Lett. 2015, 606, 94–99. [Google Scholar] [CrossRef]
  140. Liu, S.D.; Song, M.H.; Yun, W.; Lee, J.H.; Kim, H.B.; Cho, J.H. Effect of carvacrol essential oils on immune response and inflammation-related genes expression in broilers challenged by lipopolysaccharide. Poult. Sci. 2019, 98, 2026–2033. [Google Scholar] [CrossRef] [PubMed]
  141. Silva, J.C.; Almeida, J.R.G.S.; Quintans, J.S.S.; Gopalsamy, R.G.; Shanmugam, S.; Serafini, M.R.; Oliveira, M.R.C.; Silva, B.A.F.; Martins, A.O.B.P.B.; Castro, F.F.; et al. Enhancement of orofacial antinociceptive effect of carvacrol, a monoterpene present in oregano and thyme oils, by β-cyclodextrin inclusion complex in mice. Biomed. Pharmacother. 2016, 84, 454–461. [Google Scholar] [CrossRef] [PubMed]
  142. Fernandes, E.S.; Passos, G.F.; Medeiros, R.; da Cunha, F.M.; Ferreira, J.; Campos, M.M.; Pianowski, L.F.; Calixto, J.B. Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur. J. Pharmacol. 2007, 569, 228–236. [Google Scholar] [CrossRef]
  143. Rogerio, A.P.; Andrade, E.L.; Leite, D.F.P.; Figueiredo, C.P.; Calixto, J.B. Preventive and therapeutic anti-inflammatory properties of the sesquiterpene α-humulene in experimental airways allergic inflammation. Br. J. Pharmacol. 2009, 158, 1074–1087. [Google Scholar] [CrossRef] [Green Version]
  144. Aguilar-Ávila, D.S.; Flores-Soto, M.E.; Tapia-Vázquez, C.; Pastor-Zarandona, O.A.; López-Roa, R.I.; Viveros-Paredes, J.M. β-Caryophyllene, a natural sesquiterpene, attenuates neuropathic pain and depressive-like behavior in experimental diabetic mice. J. Med. Food 2019, 22, 460–468. [Google Scholar] [CrossRef] [PubMed]
  145. Hernandez-Leon, A.; González-Trujano, M.E.; Narváez-González, F.; Pérez-Ortega, G.; Rivero-Cruz, F.; Aguilar, M.I. Role of β-caryophyllene in the antinociceptive and anti-inflammatory effects of Tagetes lucida Cav. essential oil. Molecules 2020, 25, 675. [Google Scholar] [CrossRef] [Green Version]
  146. Aldred, E. Terpenes. In Pharmacology; Aldred, E., Buck, C., Kenneth, V., Eds.; Churchill Livingstone: London, UK, 2009; pp. 167–174. [Google Scholar] [CrossRef]
  147. Vestri Alvarenga, S.; Pierre Gastmans, J.; Do Vale Rodrigues, G.; Moreno, P.R.H.; De Paulo Emerenciano, V. A computer-assisted approach for chemotaxonomic studies—Diterpenes in Lamiaceae. Phytochemistry 2001, 56, 583–595. [Google Scholar] [CrossRef]
  148. Maione, F.; Cantone, V.; Pace, S.; Chini, M.G.; Bisio, A.; Romussi, G.; Pieretti, S.; Werz, O.; Koeberle, A.; Mascolo, N.; et al. Anti-inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions. Br. J. Pharmacol. 2017, 174, 1497–1508. [Google Scholar] [CrossRef] [Green Version]
  149. Mengoni, E.S.; Vichera, G.; Rigano, L.A.; Rodriguez-Puebla, M.L.; Galliano, S.R.; Cafferata, E.E.; Pivetta, O.H.; Moreno, S.; Vojnov, A.A. Suppression of COX-2, IL-1β and TNF-α expression and leukocyte infiltration in inflamed skin by bioactive compounds from Rosmarinus officinalis L. Fitoterapia 2011, 82, 414–421. [Google Scholar] [CrossRef] [PubMed]
  150. Zhao, Y.; Sedighi, R.; Wang, P.; Chen, H.; Zhu, Y.; Sang, S. Carnosic acid as a major bioactive component in Rosemary extract ameliorates high-fat-diet-induced obesity and metabolic syndrome in mice. J. Agric. Food Chem. 2015, 63, 4843–4852. [Google Scholar] [CrossRef] [PubMed]
  151. Dzubak, P.; Hajduch, M.; Vydra, D.; Hustova, A.; Kvasnica, M.; Biedermann, D.; Markova, L.; Urban, M.; Sarek, J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep. 2006, 23, 394–411. [Google Scholar] [CrossRef] [PubMed]
  152. An, H.J.; Kim, I.T.; Park, H.J.; Kim, H.M.; Choi, J.H.; Lee, K.T. Tormentic acid, a triterpenoid saponin, isolated from Rosa rugosa, inhibited LPS-induced iNOS, COX-2, and TNF-α expression through inactivation of the nuclear factor-κb pathway in RAW 264.7 macrophages. Int. Immunopharmacol. 2011, 11, 504–510. [Google Scholar] [CrossRef] [PubMed]
  153. Park, H.-J.; Nam, J.-H.; Jung, H.-J.; Lee, M.-S.; Lee, K.-T.; Jung, M.-H.; Choi, J.-W. Inhibitory effect of euscaphic acid and tormentic acid from the roots of Rosa rugosa on high fat diet-induced obesity in the rat. Korean J. Pharmacogn. 2005, 36, 324–331. [Google Scholar]
  154. De las Heras, B.; Navarro, A.; Godoy, A.; Villar, A.M. Inhibition of the induction of nitric oxide synthase in J774 macrophages by andalusol, a diterpenoid from Sideritis foetens Clem. Pharm. Pharmacol. Lett. 1997, 7, 111–112. [Google Scholar]
  155. De Las Heras, B.; Navarro, A.; Díaz-Guerra, M.J.; Bermejo, P.; Castrillo, A.; Boscá, L.; Villar, A. Inhibition of NOS-2 expression in macrophages through the inactivation of NF-κB by andalusol. Br. J. Pharmacol. 1999, 128, 605–612. [Google Scholar] [CrossRef] [Green Version]
  156. Li, Y.; Zhou, Y. The therapeutic effect of tanshinone IIA on Propionibacterium acnes -induced inflammation in vitro. Dermatol. Ther. 2018, 31, 12716. [Google Scholar] [CrossRef]
  157. McCurdy, C.R.; Sufka, K.J.; Smith, G.H.; Warnick, J.E.; Nieto, M.J. Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol. Biochem. Behav. 2006, 83, 109–113. [Google Scholar] [CrossRef]
  158. Pittaluga, A.; Olivero, G.; Di Prisco, S.; Merega, E.; Bisio, A.; Romussi, G.; Grilli, M.; Marchi, M. Effects of the neoclerodane hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system. NeuroChem. Int. 2013, 62, 354–359. [Google Scholar] [CrossRef]
  159. Otuki, M.F.; Ferreira, J.; Lima, F.V.; Meyre-silva, C.; Muller, L.; Cani, G.S.; Santos, A.R.S.; Yunes, R. Antinociceptive properties of mixture of α-amyrin and β-amyrin triterpenes: Evidence for participation of Protein Kinase C and Protein Kinase A pathways. J Pharmacol. Exp. Ther. 2005, 313, 310–318. [Google Scholar] [CrossRef] [Green Version]
  160. Quintão, N.L.M.; Rocha, L.W.; Silva, G.F.; Reichert, S.; Claudino, V.D.; Lucinda-Silva, R.M.; Malheiros, A.; Souza, M.M.; De, Filho, V.C.; Bresolin, T.M.B.; et al. Contribution of α,β-amyrenone to the anti-Inflammatory and antihypersensitivity effects of Aleurites moluccana (L.) Willd. BioMed Res. Int. 2014, 2014, 636839. [Google Scholar] [CrossRef] [Green Version]
  161. Thirupathi, A.; Silveira, P.C.; Nesi, R.T.; Pinho, R.A. β-Amyrin, a pentacyclic triterpene, exhibits anti-fibrotic, anti-inflammatory, and anti-apoptotic effects on dimethyl nitrosamine–induced hepatic fibrosis in male rats. Hum. Exp. Toxicol. 2017, 36, 113–122. [Google Scholar] [CrossRef]
  162. Kim, M.H.; Kim, J.N.; Han, S.N.; Kim, H.K. Ursolic acid isolated from guava leaves inhibits inflammatory mediators and reactive oxygen species in LPS-stimulated macrophages. Immunopharmacol. Immunotoxicol. 2015, 37, 228–235. [Google Scholar] [CrossRef]
  163. Lo, A.H.; Liang, Y.C.; Lin-Shiau, S.Y.; Ho, C.T.; Lin, J.K. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-κB in mouse macrophages. Carcinogenesis 2002, 23, 983–991. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  164. Bauer, J.; Kuehnl, S.; Rollinger, J.M.; Scherer, O.; Northoff, H.; Stuppner, H.; Werz, O.; Koeberle, A. Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase. J. Pharmacol. Exp. Ther. 2012, 342, 1222–1229. [Google Scholar] [CrossRef] [Green Version]
  165. Subbaramaiah, K.; Cole, P.; Dannenberg, A.J. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res. 2002, 62, 2522–2530. [Google Scholar]
  166. Maia, J.L.; Lima-Júnior, R.C.P.; Melo, C.M.; David, J.P.; David, J.M.; Campos, A.R.; Santos, F.A.; Rao, V.S.N. Oleanolic acid, a pentacyclic triterpene attenuates capsaicin-induced nociception in mice: Possible mechanisms. Pharmacol. Res. 2006, 54, 282–286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  167. Park, S.H.; Sim, Y.B.; Kang, Y.J.; Kim, S.S.; Kim, C.H.; Kim, S.J.; Suh, H.W. Mechanisms involved in the antinociceptive effects of orally administered oleanolic acid in the mouse. Arch. Pharm. Res. 2013, 36, 905–911. [Google Scholar] [CrossRef] [PubMed]
  168. Oliveira Costa, J.F.; Barbosa-Filho, J.M.; De Azevedo Maia, G.L.; Guimarães, E.T.; Meira, C.S.; Ribeiro-Dos-Santos, R.; Pontes De Carvalho, L.C.; Soares, M.B.P. Potent anti-inflammatory activity of betulinic acid treatment in a model of lethal endotoxemia. Int. Immunopharmacol. 2014, 23, 469–474. [Google Scholar] [CrossRef] [Green Version]
  169. Tsai, J.C.; Peng, W.H.; Chiu, T.H.; Lai, S.C.; Lee, C.Y. Anti-inflammatory effects of Scoparia dulcis L. and betulinic acid. Am. J. Chin. Med. 2011, 39, 943–953. [Google Scholar] [CrossRef] [Green Version]
  170. Petersen, M.; Simmonds, M.S.J. Rosmarinic acid. Phytochemistry 2003, 62, 121–125. [Google Scholar] [CrossRef]
  171. Sedano-Partida, M.D.; dos Santos, K.P.; Sala-Carvalho, W.R.; Silva-Luz, C.L.; Furlan, C.M. A review of the phytochemical profiling and biological activities of Hyptis Jacq.: A Brazilian native genus of Lamiaceae. Braz. J. Bot. 2020, 43, 213–228. [Google Scholar] [CrossRef]
  172. Shin, K.M.; Kim, I.T.; Park, Y.M.; Ha, J.; Choi, J.W.; Park, H.J.; Lee, Y.S.; Lee, K.T. Anti-inflammatory effect of caffeic acid methyl ester and its mode of action through the inhibition of prostaglandin E2, nitric oxide and tumor necrosis factor-α production. Biochem. Pharmacol. 2004, 68, 2327–2336. [Google Scholar] [CrossRef]
  173. Quideau, S.; Deffieux, D.; Douat-Casassus, C.; Pouységu, L. Plant polyphenols: Chemical properties, biological activities, and synthesis. Angew. Chem. Int. Ed. 2011, 50, 586–621. [Google Scholar] [CrossRef] [PubMed]
  174. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20, 933–956. [Google Scholar] [CrossRef]
  175. Wojdyło, A.; Oszmiański, J.; Czemerys, R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007, 105, 940–949. [Google Scholar] [CrossRef]
  176. Petruk, G.; Del Giudice, R.; Rigano, M.M.; Monti, D.M. Antioxidants from plants protect against skin photoaging. Oxid. Med. Cell. Longev. 2018, 2018, 1454936. [Google Scholar] [CrossRef] [Green Version]
  177. Spaak, J.; Merlocco, A.C.; Soleas, G.J.; Tomlinson, G.; Morris, B.L.; Picton, P.; Notarius, C.F.; Chan, C.T.; Floras, J.S. Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter. Am. J. Physiol. Hear. Circ. Physiol. 2008, 294, H605–H612. [Google Scholar] [CrossRef] [Green Version]
  178. Spiteller, G. Lipid peroxidation in aging and age-dependent diseases. Exp. Gerontol. 2001, 36, 1425–1457. [Google Scholar] [CrossRef]
  179. Letenneur, L.; Proust-Lima, C.; Le Gouge, A.; Dartigues, J.F.; Barberger-Gateau, P. Flavonoid intake and cognitive decline over a 10-year period. Am. J. Epidemiol. 2007, 165, 1364–1371. [Google Scholar] [CrossRef]
  180. Youdim, K.A.; Qaiser, M.Z.; Begley, D.J.; Rice-Evans, C.A.; Abbott, N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med. 2004, 36, 592–604. [Google Scholar] [CrossRef]
  181. Rahbardar, M.G.; Amin, B.; Mehri, S.; Mirnajafi-Zadeh, S.J.; Hosseinzadeh, H. Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: An evidence of anti-oxidative and anti-inflammatory effects. Phytomedicine 2018, 40, 59–67. [Google Scholar] [CrossRef] [PubMed]
  182. Feng, R.B.; Wang, Y.; He, C.; Yang, Y.; Wan, J.B. Gallic acid, a natural polyphenol, protects against tert-butyl hydroperoxide- induced hepatotoxicity by activating ERK-Nrf2-Keap1-mediated antioxidative response. Food Chem. Toxicol. 2018, 119, 479–488. [Google Scholar] [CrossRef] [PubMed]
  183. Kaur, S.; Muthuraman, A. Ameliorative effect of gallic acid in paclitaxel-induced neuropathic pain in mice. Toxicol. Rep. 2019, 6, 505–513. [Google Scholar] [CrossRef]
  184. Trevisan, G.; Rossato, M.F.; Tonello, R.; Hoffmeister, C.; Klafke, J.Z.; Rosa, F.; Pinheiro, K.V.; Pinheiro, F.V.; Boligon, A.A.; Athayde, M.L.; et al. Gallic acid functions as a TRPA1 antagonist with relevant antinociceptive and antiedematogenic effects in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2014, 387, 679–689. [Google Scholar] [CrossRef]
  185. Chauhan, P.S.; Satti, N.K.; Sharma, P.; Sharma, V.K.; Suri, K.A.; Bani, S. Differential effects of chlorogenic acid on various immunological parameters relevant to rheumatoid arthritis. Phyther. Res. 2012, 26, 1156–1165. [Google Scholar] [CrossRef] [PubMed]
  186. Hara, K.; Haranishi, Y.; Kataoka, K.; Takahashi, Y.; Terada, T.; Nakamura, M.; Sata, T. Chlorogenic acid administered intrathecally alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model. Eur. J. Pharmacol. 2014, 723, 459–464. [Google Scholar] [CrossRef]
  187. Shan, J.; Fu, J.; Zhao, Z.; Kong, X.; Huang, H.; Luo, L.; Yin, Z. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-κB and JNK/AP-1 activation. Int. Immunopharmacol. 2009, 9, 1042–1048. [Google Scholar] [CrossRef]
  188. Makni, M.; Chtourou, Y.; Fetoui, H.; Garoui, E.M.; Boudawara, T.; Zeghal, N. Evaluation of the antioxidant, anti-inflammatory and hepatoprotective properties of vanillin in carbon tetrachloride-treated rats. Eur. J. Pharmacol. 2011, 668, 133–139. [Google Scholar] [CrossRef] [PubMed]
  189. Park, S.H.; Sim, Y.B.; Choi, S.M.; Seo, Y.J.; Kwon, M.S.; Lee, J.K.; Suh, H.W. Antinociceptive profiles and mechanisms of orally administered vanillin in the mice. Arch. Pharm. Res. 2009, 32, 1634–1649. [Google Scholar] [CrossRef] [PubMed]
  190. Liu, M.; Song, S.; Li, H.; Jiang, X.; Yin, P.; Wan, C.; Liu, X.; Liu, F.; Xu, J. The protective effect of caffeic acid against inflammation injury of primary bovine mammary epithelial cells induced by lipopolysaccharide. J. Dairy Sci. 2014, 97, 2856–2865. [Google Scholar] [CrossRef] [Green Version]
  191. Mehrotra, A.; Shanbhag, R.; Chamallamudi, M.R.; Singh, V.P.; Mudgal, J. Ameliorative effect of caffeic acid against inflammatory pain in rodents. Eur. J. Pharmacol. 2011, 666, 80–86. [Google Scholar] [CrossRef] [PubMed]
  192. Yrbas, M.D.L.A.; Morucci, F.; Alonso, R.; Gorzalczany, S. Pharmacological mechanism underlying the antinociceptive activity of vanillic acid. Pharmacol. Biochem. Behav. 2015, 132, 88–95. [Google Scholar] [CrossRef]
  193. Calixto-Campos, C.; Carvalho, T.T.; Hohmann, M.S.N.; Pinho-Ribeiro, F.A.; Fattori, V.; Manchope, M.F.; Zarpelon, A.C.; Baracat, M.M.; Georgetti, S.R.; Casagrande, R.; et al. Vanillic acid inhibits inflammatory pain by inhibiting neutrophil recruitment, oxidative stress, cytokine production, and NFκB activation in mice. J. Nat. Prod. 2015, 78, 1799–1808. [Google Scholar] [CrossRef] [PubMed]
  194. Doss, H.M.; Dey, C.; Sudandiradoss, C.; Rasool, M.K. Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal-induced inflammation in rats. Life Sci. 2016, 148, 201–210. [Google Scholar] [CrossRef]
  195. Nile, S.H.; Ko, E.Y.; Kim, D.H.; Keum, Y.S. Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activity. Braz. Pharmacogn. 2016, 26, 50–55. [Google Scholar] [CrossRef] [Green Version]
  196. Kiferle, C.; Maggini, R.; Pardossi, A. Influence of nitrogen nutrition on growth and accumulation of rosmarinic acid in sweet basil (Ocimum basilicum L.) grown in hydroponic culture. Aust. J. Crop Sci. 2013, 7, 321–327. [Google Scholar]
  197. Salmaki, Y.; Zarre, S.; Govaerts, R.; Bräuchler, C. A taxonomic revision of the genus Stachys (Lamiaceae: Lamioideae) in Iran. Bot. J. Linn. Soc. 2012, 170, 573–617. [Google Scholar] [CrossRef] [Green Version]
  198. Birtić, S.; Dussort, P.; Pierre, F.X.; Bily, A.C.; Roller, M. Carnosic acid. Phytochemistry 2015, 115, 9–19. [Google Scholar] [CrossRef] [Green Version]
  199. Zheng, Q.; Sun, Z.; Zhang, X.; Yuan, J.; Wu, H.; Yang, J.; Xu, X. Clerodendranoic acid, a new phenolic acid from Clerodendranthus spicatus. Molecules 2012, 17, 13656–13661. [Google Scholar] [CrossRef] [PubMed]
  200. Yimam, M.; Brownell, L.; Hodges, M.; Jia, Q. Analgesic effects of a standardized bioflavonoid composition from Scutellaria baicalensis and Acacia catechu. J. Diet. Suppl. 2012, 9, 155–165. [Google Scholar] [CrossRef] [Green Version]
  201. Mansourabadi, A.H.; Sadeghi, H.M.; Razavi, N.; Rezvani, E. Anti-inflammatory and analgesic properties of Salvigenin, Salvia officinalis flavonoid extracted. Adv. Herb. Med. 2015, 2, 31–41. [Google Scholar]
  202. Rao, Y.K.; Fang, S.H.; Hsieh, S.C.; Yeh, T.H.; Tzeng, Y.M. The constituents of Anisomeles indica and their anti-inflammatory activities. J. Ethnopharmacol. 2009, 121, 292–296. [Google Scholar] [CrossRef]
  203. Khan, M.M.; Ahmad, A.; Ishrat, T.; Khuwaja, G.; Srivastawa, P.; Khan, M.B.; Raza, S.S.; Javed, H.; Vaibhav, K.; Khan, A.; et al. Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res. 2009, 1292, 123–135. [Google Scholar] [CrossRef]
  204. Tian, R.; Yang, W.; Xue, Q.; Gao, L.; Huo, J.; Ren, D.; Chen, X. Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats. Eur. J. Pharmacol. 2016, 771, 84–92. [Google Scholar] [CrossRef] [PubMed]
  205. Rezai-Zadeh, K.; Ehrhart, J.; Bai, Y.; Sanberg, P.R.; Bickford, P.; Tan, J.; Douglas, R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J. Neuroinflamm. 2008, 5, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  206. Filho, A.W.; Filho, V.C.; Olinger, L.; De Souza, M.M. Quercetin: Further investigation of its antinociceptive properties and mechanisms of action. Arch. Pharm. Res. 2008, 31, 713–721. [Google Scholar] [CrossRef] [PubMed]
  207. Wu, C.H.; Shieh, T.M.; Wang, K.L.; Huang, T.C.; Hsia, S.M. Quercetin, a main flavonoid in onion, inhibits the PGF2α-induced uterine contraction in vitro and in vivo. J. Funct. Foods 2015, 19, 495–504. [Google Scholar] [CrossRef]
  208. Martinez, A.L.; Gonzalez-Trujano, M.E.; Aguirre-Hernandez, E.; Moreno, J.; Soto-Hernandez, M.; Lopez-Munoz, F.J. Antinociceptive activity of Tilia americana var mexicana inflorescences and quercetin in the formalin test and in an arthritic pain model in rats. Neuropharmacology 2009, 56, 564–571. [Google Scholar] [CrossRef]
  209. Jeon, I.H.; Kim, H.S.; Kang, H.J.; Lee, H.S.; Jeong, S.I.; Kim, S.J.; Jang, S.I. Anti-inflammatory and antipruritic effects of luteolin from perilla (P. frutescens L.) leaves. Molecules 2014, 19, 6941–6951. [Google Scholar] [CrossRef] [Green Version]
  210. Lodhi, S.; Vadnere, G.P.; Patil, K.D.; Patil, T.P. Protective effects of luteolin on injury induced inflammation through reduction of tissue uric acid and pro-inflammatory cytokines in rats. J. Tradit. Complement. Med. 2020, 10, 60–69. [Google Scholar] [CrossRef] [PubMed]
  211. Yang, Y.; Tan, X.; Xu, J.; Wang, T.; Liang, T.; Xu, X.; Ma, C.; Xu, Z.; Wang, W.; Li, H.; et al. Luteolin alleviates neuroinflammation via downregulating the TLR4/TRAF6/NF-κB pathway after intracerebral hemorrhage. Biomed. Pharmacother. 2020, 126, 110044. [Google Scholar] [CrossRef] [PubMed]
  212. Carballo-Villalobos, A.I.; González-Trujano, M.E.; Pellicer, F.; López-Muñoz, F.J. Antihyperalgesic effect of hesperidin improves with diosmin in experimental neuropathic pain. BioMed Res. Int. 2016, 2016, 8263463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  213. Loscalzo, L.M.; Wasowski, C.; Paladini, A.C.; Marder, M. Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur. J. Pharmacol. 2008, 580, 306–313. [Google Scholar] [CrossRef] [PubMed]
  214. Cui, J.; Wang, G.; Kandhare, A.D.; Mukherjee-Kandhare, A.A.; Bodhankar, S.L. Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-γ Bax/Bcl-2, and caspase-3. Food Chem. Toxicol. 2018, 121, 95–108. [Google Scholar] [CrossRef]
  215. Xu, Q.; Zhang, Z.F.; Sun, W.X. Effect of naringin on monosodium iodoacetate-induced osteoarthritis pain in rats. Med. Sci. Monit. 2017, 23, 3746–3751. [Google Scholar] [CrossRef] [Green Version]
  216. Pinho-Ribeiro, F.A.; Zarpelon, A.C.; Fattori, V.; Manchope, M.F.; Mizokami, S.S.; Casagrande, R.; Verri, W.A. Naringenin reduces inflammatory pain in mice. Neuropharmacology 2016, 105, 508–519. [Google Scholar] [CrossRef]
  217. Yu, D.H.; Ma, C.H.; Yue, Z.Q.; Yao, X.; Mao, C.M. Protective effect of naringenin against lipopolysaccharide-induced injury in normal human bronchial epithelium via suppression of MAPK signaling. Inflammation 2014, 38, 195–204. [Google Scholar] [CrossRef]
Figure 1. Photographs of examples of Lamiaceae from Mexican Salvias (Calosphace subgenus). (A): S. circinnata Cav., (B): S. calderoniae Bedolla & Zamudio, (C): S. concolor Lamb. ex Benth., (D): S. divinorum Epling & Játiva, (E): S. involucrate Cav., (F): S. leucantha Cav., (G): S. karwinskii Benth., (H): S. mexicana L. (I): S. microphylla Kunth, (J): S. oaxacana Fernald, (K): S. pubescens Benth., (L): S. semiartrata, (M): S. tilantongensis J.G. González & Aguilar-Sant. and (N): S. wagneriana Zucc.
Figure 1. Photographs of examples of Lamiaceae from Mexican Salvias (Calosphace subgenus). (A): S. circinnata Cav., (B): S. calderoniae Bedolla & Zamudio, (C): S. concolor Lamb. ex Benth., (D): S. divinorum Epling & Játiva, (E): S. involucrate Cav., (F): S. leucantha Cav., (G): S. karwinskii Benth., (H): S. mexicana L. (I): S. microphylla Kunth, (J): S. oaxacana Fernald, (K): S. pubescens Benth., (L): S. semiartrata, (M): S. tilantongensis J.G. González & Aguilar-Sant. and (N): S. wagneriana Zucc.
Molecules 26 07632 g001
Figure 2. (A) Worldwide distribution of plants of the Lamiaceae family [1] and (B) in Mexico (Modified from Martínez-Gordillo et al. [28]).
Figure 2. (A) Worldwide distribution of plants of the Lamiaceae family [1] and (B) in Mexico (Modified from Martínez-Gordillo et al. [28]).
Molecules 26 07632 g002
Figure 3. Cladogram of Lamiaceae showing the monophyletic clades, where the different subfamilies are recognized. Subfamilies recognized by Olmstead: Ajugoideae, Lamioideae, Nepetoideae, Prostantheroideae, Scutellarioideae, Symphorematoideae, Tectonoideae, Callicarpoideae and Viticoideae (Modified from Li et al. [37]).
Figure 3. Cladogram of Lamiaceae showing the monophyletic clades, where the different subfamilies are recognized. Subfamilies recognized by Olmstead: Ajugoideae, Lamioideae, Nepetoideae, Prostantheroideae, Scutellarioideae, Symphorematoideae, Tectonoideae, Callicarpoideae and Viticoideae (Modified from Li et al. [37]).
Molecules 26 07632 g003
Table 1. Lamiaceae species used in traditional medicine for pain, inflammation treatment and/or as antioxidants.
Table 1. Lamiaceae species used in traditional medicine for pain, inflammation treatment and/or as antioxidants.
Scientific
Name
Medical PropertiesUsed
Plant Organs
Preparation
AnalgesicAnti-
Inflammatory
Antioxidant
Clinopodium vulgare L. [50] X Aerial partsHydroalcoholic extract
C. mexicanun (Benth.) Govaerts [51]X LeavesOrganic extracts
Eremostachys laciniata (L.) Bunge. [52] XAerial partsHydrodistillation,
Methanol extract
Glechoma longituba Kupr. [53] XAerial partsInfusion
Hedeoma drummondii Benth. [54] XAerial partsMaceration
H. multiflorum Benth. [55] XAerial partsInfusion
Holmskioldia sanguinea Retz. [56] X LeavesMethanol extract
Hyptis suaveolens (L.) Poit. [57]X Aerial partsHydroalcoholic extract
H. spicigera Lam. [58]XX Aerial partsHydrodistillation
Lamiumálbum L. [59] XXAerial partsHydroalcoholic extract
Lavandula angustifolia Mill. [60,61]XXXLeaves,
aerial parts
Hydrodistillation,
Ethanol extract
Leonoruscardiaca L. [62]X Aerial partsHydroalcoholic extract
Leonotis leonorus L. [63] XXAerial partsOrganic extracts
Leucasaspera Link [64]X XRootsMaceration
Marrubiumvulgare. L. [65] XLeaves,
aerial parts
Tincture,
Organic extracts
Menthapiperita L. [66] XXLeavesHydrodistillation
M. suaveolens Ehrh. [67]XXXAerial partsMethanol extract
Ocimum americanum L. [68] XAerial partsMethanol extract
O. basilicum L. [69]XX Aerial partsHydrodistillation
Phlomispurpurea L. [70]XX Aerial partsMethanol extract
P. nissolii L. [71] XLeavesDecoction
Premna herbacea Roxb. [72]XX RootsEthanol extract
P. integrifolia L. [73] X RootsOrganic and aqueous extracts
Prunellavulgaris L. [74]X XInflorescenceEthanol extract
Rosmarinus officinalis L. [75,76]XXXAerial parts,
leaves
Maceration,
Methanol extract
Salvia officinalis L. [77,78,79]XXXAerial parts,
Leaves
Infusion, Decoction,
Hydroalcoholic extract
S. hispanica L. [80] XAerial partsOrganic extracts
Scutellaria indica L. [81] X Aerial partsOrganic extracts
S. baicalensis Georgi. [82] XXAerial parts,
Roots
Aqueous extract,
Organic extract
Sideritis bilgeriana P.H. Davis [83]XXXAerial partsMaceration
S. congesta P.H. Davis & Hub.-Mor. [84] XAerial partsMaceration
Stachysbyzantina C. Koch. [85]XX Aerial partsOrganic extracts
S. inflata Benth. [86] X Aerial partsHydroalcoholic extract
Thymusserpyllum L. [87] XAerial partsHydrodistillation
T.vulgaris L. [88] XLeavesHydrodistillation
Vitexagnus-castus L. [89] X LeavesMethanol extract
V. megapotamica Cham. [90]XX LeavesHydroalcoholic extract
The scientific names were confirmed in The Plant List. Available online: http://www.theplantlist.org/ (Accessed on 2 December 2021).
Table 2. Monoterpenes and sesquiterpenes present in Lamiaceae with biological activity and their molecular targets explored in pain and inflammation.
Table 2. Monoterpenes and sesquiterpenes present in Lamiaceae with biological activity and their molecular targets explored in pain and inflammation.
CompoundStructureMechanism of ActionReferences
β-pinene Molecules 26 07632 i001Decreased expression of IL-6, TNF-α, NO, iNOS and COX-2.
Down-regulation of MAPKs phosphorylation and the NF-κB signaling pathway
[127]
Inhibition of COX-2 enzyme expression [128]
Limonene Molecules 26 07632 i002Reduction in leukocyte infiltration and TNF-α levels.[129]
Decreased production of NO, PGE2 and Pro-inflammatory cytokines[130]
Linalool Molecules 26 07632 i003Inhibition of pro-inflammatory interleukins and modulation of NMDA glutamatergic receptor.[131]
Reduction in oxidative stress and inflammation (NF-kB).[132]
Activation of opioid and muscarinic receptors[133]
Myrcene Molecules 26 07632 i004Activation of opioid receptors and presynaptic α2 adrenoreceptor.[134]
Inhibition of IL-1β-induced NO production
Increased expression of TIMP-1 and TIMP-3.
[135]
p-cymene Molecules 26 07632 i005Reduced the production of pro-inflammatory cytokine TNF-α, the migration of leukocytes, and the release of NO. Activation of opioid receptors.[136]
Reduced the calcium current density.[137]
Thymol Molecules 26 07632 i006Voltage-operated sodium channel blocker[138]
TRPA1 channel presynaptic activation[139]
Carvacrol Molecules 26 07632 i007Inhibition of expression TNF-α, IL-1β, and IL-6
Reduced the expression of NF-kB
[140]
Modulation of opioid, vanilloid and glutamate systems[141]
α-humulene Molecules 26 07632 i008Inhibition of pro-inflammatory cytokines (TNF-α and IL-1β) and PGE2 generation.
Decreased expression of iNOS and COX-2.
Inhibition of Il-5, CCL11 and LTB4 levels and P-selectin expression.
[142]
[143]
β-caryophyllene Molecules 26 07632 i009Cannabinoid receptor type 2 agonist.
Attenuation of Substance P and cytokines such as IL-1β, TNF-α, and IL-6.
[144]
Agonist to opioid, benzodiazepine, 5HT1A receptors and NO.[145]
Abbreviations: COX-2: Cyclooxygenase-2; IL-: Interleukin-; iNOS: Inducible nitric oxide synthase; LTB4: Leukotriene B4; MAPKs: Mitogen-activated protein kinase; NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells; NMDA: N-methyl-D-aspartate receptor; NO: Nitric oxide; PGE2: Prostaglandin E2; TIMP-: Tissue inhibitors of metalloproteinase-; TNF-α: Tumor necrosis factor-alpha; TRPA1: Transient receptor potential cation channel, subfamily A, member 1.
Table 3. Diterpenes and triterpenes present in Lamiaceae with biological activity and their molecular targets explored in pain and inflammation.
Table 3. Diterpenes and triterpenes present in Lamiaceae with biological activity and their molecular targets explored in pain and inflammation.
CompoundStructureMechanism of ActionReferences
Tormentic acid Molecules 26 07632 i010
Inhibition of NF-kB signaling pathway and prevents the expressions of iNOS, COX-2, and TNF-α.
[152]
Increased activity of Superoxide dismutase, glutathione peroxidase and catalase.[153]
Andalusol Molecules 26 07632 i011Inhibition of histamine[154]
Inhibition of iNOS expression by inactivation of NF-kB[155]
Tanshinone IIA Molecules 26 07632 i012TLR2/NF-kB signaling pathway blocker[156]
Salvinorin A Molecules 26 07632 i013KOR agonist.[157]
Inhibition of dopamine overflow mediated by KOR.[158]
α-amyrenone Molecules 26 07632 i014PKC and PKA activity blocker.[159]
Antioxidant activity.[160]
β-amyrenone Molecules 26 07632 i015Decreased levels of TNF-α and caspase 3
Reduction in oxidative stress.
[161]
Ursolic acid Molecules 26 07632 i016NO, PGE2 inhibitor.[162]
TRPV1 antagonist.
Modulator of cGMP and serotonergic system.
[115]
Carnosol Molecules 26 07632 i017Suppression of iNOS by down-regulation of NF-kB.[163]
Suppression of PGE2 synthesis by the inhibition of mPGES-1.[164]
Inhibition of the induction of COX-2 by blocking PKC signaling and thereby the binding of AP-1 to the CRE of the COX-2 promoter.[165]
Oleanolic acid Molecules 26 07632 i018Opioid agonist.
NO inhibitor.
Activation of ATP-gated K+ channels.
[166]
Opioid and 5-HT agonist. [167]
Betulinic acid Molecules 26 07632 i019Reduction in TNF-α production.
Increase in IL-10 production.
[168]
Reduction in the levels of COX-2, NO, TNF-α and IL-1β.
Inhibition of MDA level via increasing the activities of SOD, GPx, GRd.
[169]
Abbreviations: 5HT: 5-hydroxytryptamine; 5HT1A: Serotonin 1A receptor; AP-1: activator protein 1; ATP: Adenosine triphosphate; CCL11: C-C motif chemokine 11; cGMP: Cyclic guanosine monophosphate; COX-2: Cyclooxygenase-2; CRE: cyclic AMP response element; GPx: glutathione peroxidase; GRd: glutathione reductase; IL-: Interleukin-; iNOS: Inducible nitric oxide synthase; KOR: κ-opioid receptor; LTB4: Leukotriene B4; MDA: Malondialdehyde; mPGES-1: Microsomal prostaglandin E synthase-1; NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells; NO: Nitric oxide; PGE2: Prostaglandin E2; PKA: protein kinase A; PKC: protein kinase C; SOD: Superoxide dismutase; TLR2: Toll-like receptor 2; TNF-α: Tumor necrosis factor-alpha; TRPV1: Transient receptor potential cation channel subfamily V member 1.
Table 4. Phenolic acids commonly found in Lamiaceae and their molecular targets explored in pain and inflammation.
Table 4. Phenolic acids commonly found in Lamiaceae and their molecular targets explored in pain and inflammation.
CompoundStructureMechanisms of ActionReferences
Rosmarinic acid Molecules 26 07632 i020Antioxidant activity.[75]
Suppression of TNF-α, iNOs, apoptotic factors (Bax, caspases 3 and 9), Iba-1, TLR4 and GFAP levels.[181]
Gallic acid Molecules 26 07632 i021ERK-Nrf2-Keap1-mediated antioxidant activity.[182]
Reduction in TBARS, total calcium, TNF-α, superoxide anion, and MPO activity levels; and decreased GSH level.[183]
TRPA1 antagonist.[184]
Chlorogenic acid Molecules 26 07632 i022Inhibition of CD80/86 and Th1 cytokines.[185]
GABAA receptor agonist.[186]
Inhibition of NF-kB and JNK/AP-1 signaling pathways.[187]
Vanillin Molecules 26 07632 i023Inhibition of protein and lipid oxidation processes. Increased activity of GSH, SOD, catalase.Suppresses the expression of TNF-α, IL-6, IL-1β and plasma AST and ALT enzymes.[188]
α2-adrenergic and opioid receptor agonist[189]
Caffeic acid Molecules 26 07632 i024Reduction in the IκBα degradation and p65 phosphorylation in the NF-kB pathway.[190]
Inhibition of MPO, MDA and nitrite generation.[191]
Vanillic acid Molecules 26 07632 i025α2-adrenoceptor agonist.5HT3 and 5HT1 receptor agonist Interaction with TRPV1, TRPA1 and TRPM8 receptors. [192]
Inhibition of oxidative stress, pro-inflammatory cytokine production, and NF-kB activation.[193]
Ferulic acid Molecules 26 07632 i026The level/activity of elastase, lysosomal enzymes, nitric oxide, lipid peroxidation, and pro-inflammatory cytokines (TNF-α and IL-1β); and the mRNA expression of NLRP3 inflammasomes, caspase-1, pro-inflammatory cytokines, and NF-kB p65 were decreased.[194]
Inhibition of xanthine oxidase and COX-2 enzyme.[195]
Abbreviations: 5HT: Serotonin; ALT: Alanine aminotransferase; AP-1: Activator protein 1; AST: Aspartate aminotransferase; Bax: Bcl-2-associated X protein; CD80/86: CD28 receptor binds to the B7; COX-2: Cyclooxygenase-2; ERK: Extracellular-signal-regulated kinase; GABAA: γ-aminobutyric acid type A receptor; GFAP: Glial fibrillary acidic protein; GSH: Glutathione; Iba-1: Ionized calcium-binding adapter molecule 1; IL-: Interleukin-; iNOS: Inducible nitric oxide synthase; IkBα: Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; JNK: c-Jun N-terminal kinase; Keap1: Kelch-like ECH-associated protein 1; MDA: Malondialdehyde; MPO: Myeloperoxidase; mRNA: Messenger Ribonucleic acid; NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells; NLRP3: Family pyrin domain containing 3; NRf2: nuclear factor erythroid 2–related factor 2; p65: Nuclear factor NF-kappa-B p65 subunit; SOD: Superoxide dismutase; TBARS: Thiobarbituric acid reactive substances; Th1: T helper type 1; TLR4: Toll like receptor 4; TNF-α: Tumor necrosis factor-alpha; TNF-α: Tumor necrosis factor-alpha; TRPA1: Transient receptor potential ankyrin 1; TRPA1: Transient receptor potential cation channel, subfamily A, member 1; TRPM8: Transient receptor potential cation channel subfamily M (melastatin), member 8; TRPV1: Transient receptor potential cation channel subfamily V member 1.
Table 5. Flavonoids commonly present in Lamiaceae and their molecular targets explored in pain and inflammation.
Table 5. Flavonoids commonly present in Lamiaceae and their molecular targets explored in pain and inflammation.
CompoundStructureMechanism of ActionReferences
Pedalitin Molecules 26 07632 i027Inhibitory effects against NO, TNF-α and IL-12.[202]
Rutin Molecules 26 07632 i028Increased activity of GPx, GRd, CAT, SOD and GSH.[203]
Central modulation of the vlPAG descending circuit partly mediated by an opioidergic mechanism.[106]
Increased H2S level.Modulation of Nrf2 pathway. Caspase 3 and, NF-kB, TNF-α, IL-6 decreased.Increased sensory nerve conduction velocity.[204]
Apigenin Molecules 26 07632 i029Increased expression levels of Nrf2 and HO-1.Inhibition of TNF-α, IL-1β, IL-6, MPO and MDA content.[24]
Inhibition of CD40, TNF-α and IL-6[205]
Quercetin Molecules 26 07632 i030Interaction with L-arginine-nitric oxide, serotonin, and GABAergic systems.[206]
ROCs and VOCs Blocker Modulation of PGF2α pathway [207]
5HT1A agonist[208]
Luteolin Molecules 26 07632 i031Inhibition of IL-1β, TNF-α and histamine release. [209]
Decreased neutrophil infiltration.Inhibition of TNF-α, IL-1β, IL-6.[210]
Downregulation of TLR4/TRAF6/NF-kB pathway[211]
Inhibition of CD40, TNF-α and IL-6[205]
Hesperidin Molecules 26 07632 i032Modulation of D2, GABAA and opioid receptors.[212]
Agonist of opioid receptors.[213]
Modulation of TRPV1 receptor.[189]
Naringin Molecules 26 07632 i033Inhibition of oxido-nitrosative strees, TNF-α, IL’s and NF-kB mRNA levels.[214]
Inhibition of PGE2, NO, IL-6 and TNF-α.[215]
Naringenin Molecules 26 07632 i034Inhibition of NF-kB and activation of NO-Cyclic GMP-PKG-ATP sensitive K+ channel pathway [216]
Inhibition of IL-6, TNF-α and NO release, by interfering MAPK signal pathway and suppressing the activation of NF-kB.[217]
Abbreviations: 5HT1A: Serotonin 1A receptor; ATP: Adenosine triphosphate; CAT: Catalase; CD40: Cluster of differentiation 40; GABA: γ aminobutyric acid; GMP: Cyclic guanosine monophosphate; GPx: glutathione peroxidase; GRd: glutathione; reductase; GSH: Glutathione; H2S: Hydrogen sulfide; HO-1: Heme oxygenase-1; IL-: Interleukin-; MAPK: Mitogen-activated protein kinase; MDA: Malondialdehyde; MPO: Myeloperoxidase; mRNA: Messenger Ribonucleic acid; NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells; NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells; NO: Nitric oxide; Nrf2: Nuclear factor erythroid 2–related factor 2; PGE2: Prostaglandin E2; PGF2α: Prostaglandin F2α: PKG: cGMP-dependent protein kinase ROCs: Receptor-operated channels; SOD: Superoxide dismutase; TLR4: Toll-like receptor 4; TNF-α: Tumor necrosis factor-alpha; TRAF6: TNF receptor associated factor 6; TRPV1: Transient receptor potential cation channel subfamily V member 1; VOCs: Voltage-operated channels.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hernandez-Leon, A.; Moreno-Pérez, G.F.; Martínez-Gordillo, M.; Aguirre-Hernández, E.; Valle-Dorado, M.G.; Díaz-Reval, M.I.; González-Trujano, M.E.; Pellicer, F. Lamiaceae in Mexican Species, a Great but Scarcely Explored Source of Secondary Metabolites with Potential Pharmacological Effects in Pain Relief. Molecules 2021, 26, 7632. https://doi.org/10.3390/molecules26247632

AMA Style

Hernandez-Leon A, Moreno-Pérez GF, Martínez-Gordillo M, Aguirre-Hernández E, Valle-Dorado MG, Díaz-Reval MI, González-Trujano ME, Pellicer F. Lamiaceae in Mexican Species, a Great but Scarcely Explored Source of Secondary Metabolites with Potential Pharmacological Effects in Pain Relief. Molecules. 2021; 26(24):7632. https://doi.org/10.3390/molecules26247632

Chicago/Turabian Style

Hernandez-Leon, Alberto, Gabriel Fernando Moreno-Pérez, Martha Martínez-Gordillo, Eva Aguirre-Hernández, María Guadalupe Valle-Dorado, María Irene Díaz-Reval, María Eva González-Trujano, and Francisco Pellicer. 2021. "Lamiaceae in Mexican Species, a Great but Scarcely Explored Source of Secondary Metabolites with Potential Pharmacological Effects in Pain Relief" Molecules 26, no. 24: 7632. https://doi.org/10.3390/molecules26247632

APA Style

Hernandez-Leon, A., Moreno-Pérez, G. F., Martínez-Gordillo, M., Aguirre-Hernández, E., Valle-Dorado, M. G., Díaz-Reval, M. I., González-Trujano, M. E., & Pellicer, F. (2021). Lamiaceae in Mexican Species, a Great but Scarcely Explored Source of Secondary Metabolites with Potential Pharmacological Effects in Pain Relief. Molecules, 26(24), 7632. https://doi.org/10.3390/molecules26247632

Article Metrics

Back to TopTop